<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiovasc Diabetol</journal-id><journal-id journal-id-type="iso-abbrev">Cardiovasc Diabetol</journal-id><journal-title-group><journal-title>Cardiovascular Diabetology</journal-title></journal-title-group><issn pub-type="epub">1475-2840</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12103019</article-id><article-id pub-id-type="publisher-id">2785</article-id><article-id pub-id-type="doi">10.1186/s12933-025-02785-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Cumulative blood pressure load as a predictor of arterial stiffness progression and incident diabetic kidney disease: a multicenter longitudinal study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Cong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ji</surname><given-names>Bangqun</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liang</surname><given-names>Yao</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Shi</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yufan</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ke</surname><given-names>Tingyu</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Dong</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Yuancheng</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Qijuan</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Fengmei</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Weiqing</given-names></name><address><email>wqingw@shsmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zheng</surname><given-names>Qidong</given-names></name><address><email>yuzqd@126.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Yifei</given-names></name><address><email>feifei-a@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, </institution><institution>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>197 Ruijin 2nd Road, Shanghai, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, </institution><institution>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>197 Ruijin 2nd Road, Shanghai, China </aff><aff id="Aff3"><label>3</label>Department of Endocrinology, Xingyi People&#x02019;s Hospital, Xingyi, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042g3qa69</institution-id><institution-id institution-id-type="GRID">grid.440299.2</institution-id><institution>Department of Internal Medicine, </institution><institution>The Second People&#x02019;s Hospital of Yuhuan, </institution></institution-wrap>Yuhuan, China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04a46mh28</institution-id><institution-id institution-id-type="GRID">grid.412478.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 4628</institution-id><institution>Department of Endocrinology and Metabolism, </institution><institution>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01kq6mv68</institution-id><institution-id institution-id-type="GRID">grid.415444.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1800 0367</institution-id><institution>Department of Endocrinology, </institution><institution>The Second Affiliated Hospital of Kunming Medical University, </institution></institution-wrap>Kunming, China </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045rymn14</institution-id><institution-id institution-id-type="GRID">grid.460077.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 3393</institution-id><institution>Department of Endocrinology, </institution><institution>The First Affiliated Hospital of Ningbo University, </institution></institution-wrap>Ningbo, China </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013xs5b60</institution-id><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Center for Endocrine Metabolism and Immune Diseases, </institution><institution>Beijing Luhe Hospital, Capital Medical University, </institution></institution-wrap>Beijing, China </aff><aff id="Aff9"><label>9</label>Department of Internal Medicine of Traditional Chinese Medicine, Sheyang Diabetes Hospital, Yancheng, China </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02my3bx32</institution-id><institution-id institution-id-type="GRID">grid.257143.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1772 1285</institution-id><institution>Department of Endocrinology and Metabolism, People&#x02019;s Hospital of Zhengzhou Affiliated, </institution><institution>Henan University of Chinese Medicine, </institution></institution-wrap>Zhengzhou, China </aff><aff id="Aff11"><label>11</label>Department of Endocrinology and Metabolism, Hebi Coal (Group). LTD. General Hospital, Hebi, China </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>24</volume><elocation-id>225</elocation-id><history><date date-type="received"><day>8</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>9</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Elevated blood pressure (BP) is a key contributor to the progression of arterial stiffness and the incidence of diabetic kidney disease (DKD). Cumulative BP load enables the evaluation of long-term BP exposure, but the BP targets used to calculate it vary across studies. This study aimed to compare the predictive performance of cumulative BP load calculated using different clinically recommended BP targets.</p></sec><sec><title>Methods</title><p id="Par2">This multicenter longitudinal study included participants with type 2 diabetes from 10 diabetes centers. Cumulative BP load was calculated using various clinically recommended BP targets (SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;120&#x000a0;mmHg). The primary outcomes were the progression of arterial stiffness, assessed by brachial-ankle pulse wave velocity (ba-PWV) changes, and the incidence of DKD, defined as an estimated glomerular filtration rate&#x02009;&#x0003c;&#x02009;60&#x000a0;mL/min/1.73m<sup>2</sup> or urine albumin-to-creatinine ratio&#x02009;&#x02265;&#x02009;3.39&#x000a0;mg/mmol. The predictive ability of cumulative BP load calculated under different clinically recommended targets was compared using adjusted R squared (adjusted R<sup>2</sup>) for continuous outcomes and net reclassification improvement (NRI) for binary outcomes.</p></sec><sec><title>Results</title><p id="Par3">Among the 18,168 participants included (mean age 54.5&#x000a0;years; 57.5% male), 13,388 met all eligibility criteria for the analysis of arterial stiffness progression, and 11,145 for the analysis of DKD incidence. Over a mean follow-up of 3.5&#x000a0;years, the median ba-PWV increase was 0.19&#x000a0;m/s per year and 2,855 (25.6%) developed DKD. When cumulative BP load was added to a model containing traditional risk factors, the adjusted R<sup>2</sup> values for predicting the absolute annual change in ba-PWV were 0.193 (95% CI 0.180&#x02013;0.200), 0.184 (0.169&#x02013;0.191), and 0.172 (0.158&#x02013;0.180) with BP targets of SBP&#x02009;&#x0003c;&#x02009;120,&#x02009;&#x0003c;&#x02009;130, and&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg, respectively. For the incidence of DKD, the NRIs were 15.8% (11.5&#x02013;20.0%), 12.5% (8.3&#x02013;16.7%), and 6.4% (2.3&#x02013;10.6%) with BP targets of SBP&#x02009;&#x0003c;&#x02009;120, &#x0003c;&#x02009;130, and &#x0003c;&#x02009;140&#x000a0;mmHg, respectively.</p></sec><sec><title>Conclusion</title><p id="Par4">Cumulative BP load is an effective indicator for predicting the progression of arterial stiffness and incidence of DKD, with the best predictive performance observed when the target SBP is set at &#x0003c;&#x02009;120&#x000a0;mmHg.</p></sec><sec><title>Graphical abstract</title><p id="Par5">
<graphic position="anchor" xlink:href="12933_2025_2785_Figa_HTML" id="MO1"/>
</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12933-025-02785-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>cumulative blood pressure load</kwd><kwd>arterial stiffness</kwd><kwd>Diabetic kidney disease</kwd><kwd>Modifiable factors</kwd><kwd>Type 2 diabetes</kwd></kwd-group><funding-group><award-group><funding-source><institution>Capacity building for multidisciplinary cooperation in diagnosis and treatment of major metabolic diseases</institution></funding-source><award-id>No. Z155080000004</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Shanghai Hospital Development Center</institution></funding-source><award-id>SHDC22022301</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Noncommunicable Chronic Diseases-National Science and Technology Major Project</institution></funding-source><award-id>No.2023ZD0508100</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>the National Natural Science Foundation of China</institution></funding-source><award-id>No. 82270896</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>the Shanghai Medical and Health Development Foundation</institution></funding-source><award-id>No. DMRFP_II_01</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>The Leader Project of the Oriental Talent Program in 2022</institution></funding-source><award-id>No.153</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Research in context</title><p id="Par36">
<bold>What is currently known about this topic?</bold>
</p><p id="Par37">
<list list-type="bullet"><list-item><p id="Par38">Hypertension is a major risk factor for cardiovascular and kidney diseases.</p></list-item><list-item><p id="Par39">Single-point BP measurements poorly reflect long-term BP status.</p></list-item><list-item><p id="Par40">Cumulative BP load calculation lacks standardized target thresholds.</p></list-item></list>
</p><p id="Par41">
<bold>What is the key research question?</bold>
</p><p id="Par42">Does cumulative BP load based on different targets predict arterial stiffness progression and DKD?</p><p id="Par43">
<bold>What is new?</bold>
</p><p id="Par44">
<list list-type="bullet"><list-item><p id="Par45">Cumulative BP load based on SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg showed superior predictive performance.</p></list-item><list-item><p id="Par46">Favorable socioeconomic status was associated with lower cumulative SBP load.</p></list-item></list>
</p><p id="Par47">
<bold>How might this study influence clinical practice?</bold>
</p><p id="Par48">Cumulative BP load enhances risk prediction for arterial stiffness progression and DKD.</p></sec><sec id="Sec6"><title>Background</title><p id="Par49">Diabetes has emerged as a major global public health challenge, with the number of patients expected to exceed 1.3 billion by 2050 [<xref ref-type="bibr" rid="CR1">1</xref>]. Cardiovascular disease (CVD) remains the primary cause of morbidity and mortality among diabetic patients. Arterial stiffness, a key early indicator of vascular wall structural and functional abnormalities, is an independent predictor of cardiovascular diseases and mortality [<xref ref-type="bibr" rid="CR2">2</xref>]. In addition, diabetic kidney disease (DKD) is a recognized risk factor for cardiovascular events [<xref ref-type="bibr" rid="CR3">3</xref>]. Studies have demonstrated that patients with DKD have a twofold higher risk of cardiovascular mortality compared to those without DKD [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par50">Hypertension is a key modifiable risk factor contributing to the development of diabetic complications [<xref ref-type="bibr" rid="CR5">5</xref>]. Recently, a clinical trial demonstrated that intensive blood pressure (BP) management, targeting a systolic blood pressure (SBP) of less than 120&#x000a0;mmHg, can reduce the risk of major cardiovascular events by 21% compared to standard SBP targets (SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. However, maintaining blood pressure within recommended targets remains challenging in clinical practice, particularly for individuals with type 2 diabetes [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Although office BP measurement is widely used in clinical practice, values obtained at a single visit may not reliably represent an individual's long-term BP exposure [<xref ref-type="bibr" rid="CR10">10</xref>]. To overcome this limitation, recent studies have utilized various indices derived from BP measurements across multiple visits to better characterize the long-term burden of elevated BP. These indices include cumulative BP load, time at target (TITRE) of BP, and variability of BP [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Cumulative BP load is defined as the proportion of the area under the BP-time curve that lies above the clinically recommended BP target, relative to the total area under the BP-time curve [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. A previous study has shown that cumulative BP load improves the prediction of cardiovascular events [<xref ref-type="bibr" rid="CR16">16</xref>]. However, variations in recommended BP targets across different clinical guidelines and trials have led to inconsistent calculations for cumulative BP load, which may hinder its comparability and clinical application [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par51">Furthermore, previous studies have shown that socioeconomic status, lifestyle, and metabolic factors are strongly associated with diabetic cardio-renal complications [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. However, the role of cumulative blood pressure exposure in this relationship remains poorly understood. While research on cumulative BP load has focused on its direct associations with outcomes, it has not yet explored the upstream modifiable factors linked to this exposure. Structural equation modeling is a powerful tool to simultaneously analyze the complex relationships among multiple variables and quantify the potential pathways connecting these modifiable factors to outcomes [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par52">This study has two primary objectives in light of the current research landscape. First, we aim to compare the predictive value of cumulative BP load calculated using different clinically recommended BP control targets for predicting the progression of arterial stiffness and the incidence of DKD. Second, structural equation modeling will be applied to identify possible interrelationships among socioeconomic factors, lifestyle behaviors, metabolic profiles, cumulative BP load, and the risk of diabetic cardio-renal complications.</p></sec><sec id="Sec7"><title>Methods</title><sec id="Sec8"><title>Study population</title><p id="Par53">This study was based on a prospective, real-world cohort drawn from the National Metabolic Management Center (MMC) program, a national initiative launched in 2016 to standardize and enhance the management of diabetes and related metabolic disorders across China [<xref ref-type="bibr" rid="CR30">30</xref>]. The program employs a unified operational model (&#x0201c;One Center, One Stop, One Standard Model&#x0201d;) to ensure consistency in diagnosis, treatment, data collection, and follow-up [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par54">Participants in this analysis were recruited from 10 MMC sites located in various regions of China, including northern (Beijing), eastern (Shanghai, Zhejiang, Jiangsu), central (Henan), and southwestern (Guizhou, Yunnan) provinces. The selection of these centers has been described in the previous publication [<xref ref-type="bibr" rid="CR23">23</xref>]. Between June 2017 and July 2024, participants aged &#x02265;&#x02009;18&#x000a0;years with type 2 diabetes were enrolled. For the analysis of arterial stiffness progression, participants were included if they had at least two measurements of brachial-ankle pulse wave velocity (ba-PWV) and blood pressure records from at least four clinic visits before the final ba-PWV assessment. For the diabetic kidney disease (DKD) analysis, participants without baseline DKD&#x02014;defined as estimated glomerular filtration rate (eGFR)&#x02009;&#x02265;&#x02009;60&#x000a0;mL/min/1.73&#x000a0;m<sup>2</sup> and urine albumin-to-creatinine ratio (UACR)&#x02009;&#x0003c;&#x02009;3.39&#x000a0;mg/mmol&#x02014;were included. These participants were also required to have at least four BP measurements before DKD onset or the final assessments of eGFR and UACR. Participants were excluded if they had a follow-up period shorter than 18&#x000a0;months, missing data on baseline or outcome variables (ba-PWV, eGFR, or UACR), or fewer than four BP measurements (Figure <xref rid="MOESM1" ref-type="media">S1</xref>).</p><p id="Par55">Ethical approval was granted by the Ethical Review Committee of Ruijin Hospital, affiliated with the Shanghai Jiao Tong University School of Medicine, and by the ethics committees of all other participating centers. All participants provided written informed consent before enrollment. The study design followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.</p></sec><sec id="Sec9"><title>Data collection</title><p id="Par56">At baseline, trained personnel administered comprehensive questionnaires to participants following standardized protocols. The study protocol is publicly accessible on ClinicalTrials.gov (NCT03811470). The questionnaire covered demographics, socioeconomic status, medical history, lifestyle factors, and other relevant information [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Blood pressure was measured using two electronic BP monitors (OMRON HBP-1100 U and HBP-9031C) after participants remained seated for at least 5&#x000a0;min. For OMRON HBP-1100 U, an appropriate cuff size was selected based on the participant&#x02019;s arm circumference. The applicable arm circumference range of OMRON HBP-9031C was 17&#x02013;42&#x000a0;cm. All measurements were taken with the mid-arm supported at heart level. Raw measurement data were automatically uploaded to the proprietary electronic medical record system upon completion. All healthcare providers received standardized training before study initiation at each MMC site to ensure protocol adherence and measurement consistency. The cumulative blood pressure load was calculated for each participant based on all available BP measurements during follow-up. Specifically, it was defined as the percentage of the area under the BP-time curve where BP values exceeded a recommended BP control target, relative to the total area under the curve [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. For SBP, cumulative SBP load was assessed using three commonly recommended control targets: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;120&#x000a0;mmHg. For DBP, cumulative DBP load was calculated using two control targets: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg and &#x0003c;&#x02009;80&#x000a0;mmHg (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Conceptual illustration of cumulative SBP load (<bold>A</bold>) and cumulative DBP load (<bold>B</bold>) calculation. In accordance with current clinical practice guidelines, cumulative BP load was calculated based on three SBP control targets (&#x0003c;&#x02009;120,&#x02009;&#x0003c;&#x02009;130, and &#x0003c;&#x02009;140&#x000a0;mmHg) and two DBP control targets (&#x0003c;&#x02009;80 and &#x0003c;&#x02009;90&#x000a0;mmHg). Dashed lines represent the clinically recommended BP targets. The red-shaded areas labeled &#x0201c;A&#x0201d; represent the area above the target BP line, while the green-shaded areas labeled &#x0201c;B&#x0201d; represent values within the target range. Cumulative BP load is defined as the proportion of area A to the total area under the BP-time curve (A&#x02009;+&#x02009;B). <italic>Note</italic> To enhance visual clarity, the y-axis is truncated. The calculation of cumulative BP load was performed using the entire area under the curve</p></caption><graphic xlink:href="12933_2025_2785_Fig1_HTML" id="MO2"/></fig></p></sec><sec id="Sec10"><title>Outcomes</title><p id="Par57">The primary outcomes were the progression of arterial stiffness and the incidence of DKD. Arterial stiffness was assessed by measuring ba-PWV using an automatic device (BP-203RPE III, Form PWV/ABI, Omron Healthcare Co.) after participants rested supine for at least 5&#x000a0;min. Appropriate cuffs were placed on both upper arms and ankles to obtain brachial and tibial arterial waveforms. The ba-PWV was calculated by dividing the transmission distance between the brachium and ankle by the transmission time. The mean value of bilateral ba-PWV measurements was used for analysis [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. The incidence of DKD was defined as the presence of albuminuria (UACR&#x02009;&#x02265;&#x02009;3.39&#x000a0;mg/mmol) or reduced eGFR (&#x0003c;&#x02009;60&#x000a0;mL/min/1.73m<sup>2</sup>) [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par58">As part of the MMC program protocol, ba-PWV was scheduled to be measured at enrollment, year 2 or year 3 of follow-up, and again in year 5 (a minimum of three measurements during the five-year timeframe if possible). DKD assessment was recommended approximately every 6&#x000a0;months during follow-up.</p><p id="Par59">Arterial stiffness progression was evaluated using two complementary approaches. First, annual changes in ba-PWV were calculated in two forms: (1) absolute change, defined as (last ba-PWV&#x02014;first ba-PWV) / time interval (in m/s per year); and (2) relative change, defined as [(last ba-PWV- first ba-PWV) / first ba-PWV]&#x02009;&#x000d7;&#x02009;100/time interval (in % per year) [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Second, participants were stratified into two subgroups based on whether their final ba-PWV measurements showed increased/consistently high or decreased/consistently low compared to their initial measurements (Figure <xref rid="MOESM1" ref-type="media">S2</xref>). Initial and final ba-PWV measurements were divided into quartiles to establish this classification. Participants were categorized into either the increased/consistently high group (third and fourth quartiles) or the decreased/consistently low group (first and second quartiles) [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par60">Continuous variables were presented as mean&#x02009;&#x000b1;&#x02009;SD or median (interquartile range), while categorical variables were summarized as counts and percentages. Group differences were assessed using Student's t-test, Wilcoxon rank-sum test, or chi-square test, as appropriate. Missing baseline covariate data were estimated using multiple imputations by chained equations (MICE). All covariates had missing data proportions below 10% (Table <xref rid="MOESM1" ref-type="media">S1</xref>). Results from five imputed datasets were combined using Rubin's rules to obtain overall estimates [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par61">Since cumulative BP load was calculated based on repeated BP measurements obtained at multiple clinical visits throughout the follow-up period, multivariable linear regression models were fitted using both absolute and relative annual ba-PWV change as continuous outcomes and logistic regression models were employed to evaluate the independent effects on the categorical outcomes. These analyses adjusted for baseline covariates including age, sex, diabetes duration, blood pressure, glycated hemoglobin (HbA1c), body mass index (BMI), triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications. In addition, the number of BP measurements was included as a covariate in all models to account for differences in measurement frequency. Analyses for arterial stiffness progression were additionally adjusted for baseline ba-PWV, while models for incident DKD were adjusted for baseline eGFR. Collinearity diagnosis was examined using the variance inflation factor (VIF) and a VIF&#x02009;&#x02265;&#x02009;2.5 was considered indicative of collinearity [<xref ref-type="bibr" rid="CR39">39</xref>]. Nonlinear relationships between cumulative BP load and outcomes were assessed using restricted cubic splines (RCS), with four knots at the 5th, 35th, 65th, and 95th percentiles of cumulative BP load. The nonlinearity assumption was tested using the Wald test.</p><p id="Par62">To compare the predictive performance of the cumulative BP load for the progression of arterial stiffness and the incidence of DKD, we used adjusted R squared (adjusted R<sup>2</sup>) and its 95% confidence interval (CI) for continuous outcomes and C-statistics, net reclassification improvement (NRI), and Akaike information criterion (AIC) for categorical outcomes [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par63">Structural equation modeling was performed for path analysis to systematically explore the relationships among socioeconomic status, lifestyle factors, metabolic indicators, and their possible direct and indirect relationships with cumulative BP load and diabetic cardio-renal complications. Risk factors for the structural equation model were selected based on existing literature and practical considerations, including biological plausibility, statistical association with diabetic complications, modifiability, availability in the database, and low levels of missing data. A detailed summary of the selection criteria is provided in Table <xref rid="MOESM1" ref-type="media">S2</xref>. Detailed measurements and definitions for all these modifiable factors are provided in the Supplementary Methods.</p><p id="Par64">The temporal sequence determined exposure and mediating factors: education level typically preceded occupational status, household income, and lifestyle factors, which precede baseline metabolic indicators. Cumulative BP load was calculated during the follow-up period, while the progression of arterial stiffness and the incidence of DKD outcomes were determined after the final BP measurement. All continuous variables were standardized to enable a more straightforward comparison of path coefficients. Bootstrap methods were used for parameter estimation and robustness analysis, with standard errors obtained through 5,000 resampling iterations. The final model was adjusted for age and sex to reduce confounding bias and optimized based on modification indices [<xref ref-type="bibr" rid="CR43">43</xref>]. The model fit was evaluated using several indices, including the root mean square error of approximation (RMSEA), where values of &#x02264;&#x02009;0.06 indicate a good fit and &#x02264;&#x02009;0.08 suggest an adequate fit; the comparative fit index (CFI), with &#x02265;&#x02009;0.95 indicating a good fit and &#x02265;&#x02009;0.90 representing an adequate fit; and the Tucker-Lewis index (TLI), where a value of &#x02265;&#x02009;0.95 is considered a good fit and &#x02265;&#x02009;0.90 is considered an adequate [<xref ref-type="bibr" rid="CR44">44</xref>]. Path coefficients were interpreted based on their direction, magnitude, and statistical significance (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), with standardized coefficients clarifying the relative impact of different predictive factors.</p><p id="Par65">All statistical analyses were performed using R version 4.4.2 (R Foundation). Statistical significance was determined at a two-sided <italic>P</italic>-value of &#x0003c;&#x02009;0.05.</p></sec><sec id="Sec12"><title>Sensitivity analyses</title><p id="Par66">First, although we adjusted for baseline cardiovascular disease status in the primary analyses, we excluded patients with a history of cardiovascular disease from the arterial stiffness progression cohort to assess the impact of excluding this subgroup from the primary sample. Second, we stratified patients according to their baseline hypertension history and compared the optimal target values for calculating cumulative BP load between the two groups. Third, we evaluated the predictive value of two indicators, BP TITRE and BP variability, on cardio-renal outcomes. BP TITRE was defined as the percentage of days during follow-up when blood pressure remained below the BP control target [<xref ref-type="bibr" rid="CR12">12</xref>]. Using the same methodology as for cumulative BP load, we assessed SBP TITRE with three control targets: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg, SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg, and SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg, and DBP TITRE with two control targets: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg and DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg. BP variability was evaluated using the standard deviation (SD) of all BP measurements to assess overall variability and average real variability (ARV) to quantify the mean absolute differences between these measurements [<xref ref-type="bibr" rid="CR45">45</xref>]. Fourth, we conducted an additional evaluation in a subsample of participants with BP measurements recorded at baseline, 6 (&#x000b1;&#x02009;1&#x000a0;month), 12 (&#x000b1;&#x02009;1&#x000a0;month), and 18&#x000a0;months (&#x000b1;&#x02009;1&#x000a0;month). In this subset, cumulative BP load was recalculated using only these four time points to ensure comparability of measurement intervals across individuals. Finally, to assess the potential impact of variability in BP measurement devices, we conducted a sensitivity analysis restricted to a small subset of participants who measured BP using the OMRON HBP-9031C device.</p></sec></sec><sec id="Sec13"><title>Results</title><sec id="Sec14"><title>Baseline characteristics</title><p id="Par67">Between June 2017 and July 2024, a total of 33,872 participants with type 2 diabetes had a follow-up duration of at least 1.5&#x000a0;years. After applying the inclusion and exclusion criteria, 18,168 participants were included in the final analysis&#x02014;13,388 for arterial stiffness progression analysis and 11,145 for DKD incidence analysis. Baseline characteristics of participants included in the analysis versus those excluded are presented in Table <xref rid="MOESM1" ref-type="media">S3</xref>. Throughout the study period, 131,973 blood pressure measurements were recorded, with each participant having an average of six measurements. We visualized the number of BP measurements of all participants using frequency histograms (Figure <xref rid="MOESM1" ref-type="media">S3</xref>). The distribution of cumulative BP load, calculated based on these blood pressure measurements from the two cohorts, is shown in Figures <xref rid="MOESM1" ref-type="media">S4</xref> and <xref rid="MOESM1" ref-type="media">S5</xref>.</p><p id="Par68">Table <xref rid="Tab1" ref-type="table">1</xref> presents the baseline characteristics of the study participants. The participants had a mean (SD) age of 54.5 (11.0) years, and 10,453 (57.5%) were male. During a mean follow-up period of 3.5&#x000a0;years, the median annual increase in ba-PWV was 0.19&#x000a0;m/s. Among the participants analyzed, arterial stiffness progression occurred in 6,366 (47.6% of 13,388), and incident DKD occurred in 2,855 (25.6% of 11,145). Participants with arterial stiffness progression were older and had a longer duration of diabetes compared to those without progression. They also exhibited a higher prevalence of cardiovascular disease and hypertension. Similarly, participants who developed DKD were older and had a longer duration of diabetes. They also exhibited a higher prevalence of cardiovascular disease and were more likely to have a history of hypertension compared to those who did not develop DKD.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Baseline characteristics of participants stratified by arterial stiffness progression and the incidence of diabetic kidney disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Overall</th><th align="left">Progression of arterial stiffness</th><th align="left">No Progression of arterial stiffness</th><th align="left"><italic>P</italic></th><th align="left">Overall</th><th align="left">Diabetic kidney disease</th><th align="left">No diabetic kidney disease</th><th align="left"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">No. of participants</td><td align="left">13,388</td><td align="left">6,366</td><td align="left">7,022</td><td char="." align="char"/><td align="left">11,145</td><td align="left">2,855</td><td align="left">8,290</td><td char="." align="char"/></tr><tr><td align="left">Age, years</td><td align="left">54.83&#x02009;&#x000b1;&#x02009;10.96</td><td align="left">58.51&#x02009;&#x000b1;&#x02009;9.62</td><td align="left">51.50&#x02009;&#x000b1;&#x02009;11.03</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">53.46&#x02009;&#x000b1;&#x02009;10.93</td><td align="left">55.83&#x02009;&#x000b1;&#x02009;10.81</td><td align="left">52.65&#x02009;&#x000b1;&#x02009;10.85</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Males, n (%)</td><td align="left">7,555 (56.43%)</td><td align="left">3,324 (52.21%)</td><td align="left">4,231 (60.25%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">6,655 (59.71%)</td><td align="left">1,491 (52.22%)</td><td align="left">5,164 (62.29%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Duration of diabetes, years</td><td align="left">7.68&#x02009;&#x000b1;&#x02009;7.00</td><td align="left">9.07&#x02009;&#x000b1;&#x02009;7.27</td><td align="left">6.43&#x02009;&#x000b1;&#x02009;6.50</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">6.14&#x02009;&#x000b1;&#x02009;6.51</td><td align="left">7.39&#x02009;&#x000b1;&#x02009;7.00</td><td align="left">5.71&#x02009;&#x000b1;&#x02009;6.28</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">History of CVD, %</td><td align="left">1,825 (13.68%)</td><td align="left">1,062 (16.75%)</td><td align="left">763 (10.90%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">1,277 (11.54%)</td><td align="left">411 (14.49%)</td><td align="left">866 (10.53%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">History of hypertension, %</td><td align="left">5,869 (44.40%)</td><td align="left">3,247 (51.73%)</td><td align="left">2,622 (37.78%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">3,851 (35.03%)</td><td align="left">1,262 (45.01%)</td><td align="left">2,589 (31.61%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Education level, n (%)</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Less than high school</td><td align="left">7,819 (58.55%)</td><td align="left">3,840 (60.46%)</td><td align="left">3,979 (56.81%)</td><td char="." align="char"/><td align="left">5,531 (49.93%)</td><td align="left">1,675 (59.06%)</td><td align="left">3,856 (46.79%)</td><td char="." align="char"/></tr><tr><td align="left">High school or further</td><td align="left">5,536 (41.45%)</td><td align="left">2,511 (39.54%)</td><td align="left">3,025 (43.19%)</td><td char="." align="char"/><td align="left">5,546 (50.07%)</td><td align="left">1,161 (40.94%)</td><td align="left">4,385 (53.21%)</td><td char="." align="char"/></tr><tr><td align="left">Occupation</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.014</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Intermediate or low grade</td><td align="left">9,526 (71.30%)</td><td align="left">4,594 (72.31%)</td><td align="left">4,932 (70.39%)</td><td char="." align="char"/><td align="left">7,494 (67.56%)</td><td align="left">2,085 (73.42%)</td><td align="left">5,409 (65.55%)</td><td char="." align="char"/></tr><tr><td align="left">High grade</td><td align="left">3,834 (28.70%)</td><td align="left">1,759 (27.69%)</td><td align="left">2,075 (29.61%)</td><td char="." align="char"/><td align="left">3,598 (32.44%)</td><td align="left">755 (26.58%)</td><td align="left">2,843 (34.45%)</td><td char="." align="char"/></tr><tr><td align="left">Annual Household Income, thousand CNY</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x0003c;&#x02009;10</td><td align="left">445 (3.57%)</td><td align="left">249 (4.15%)</td><td align="left">196 (3.04%)</td><td char="." align="char"/><td align="left">365 (3.56%)</td><td align="left">105 (3.92%)</td><td align="left">260 (3.44%)</td><td char="." align="char"/></tr><tr><td align="left">10&#x02013;30</td><td align="left">1,812 (14.56%)</td><td align="left">1,000 (16.66%)</td><td align="left">812 (12.60%)</td><td char="." align="char"/><td align="left">1,336 (13.04%)</td><td align="left">412 (15.38%)</td><td align="left">924 (12.22%)</td><td char="." align="char"/></tr><tr><td align="left">31&#x02013;100</td><td align="left">4,860 (39.04%)</td><td align="left">2,270 (37.81%)</td><td align="left">2,590 (40.19%)</td><td char="." align="char"/><td align="left">3,904 (38.12%)</td><td align="left">1,065 (39.75%)</td><td align="left">2,839 (37.54%)</td><td char="." align="char"/></tr><tr><td align="left">101&#x02013;300</td><td align="left">3,186 (25.59%)</td><td align="left">1,357 (22.60%)</td><td align="left">1,829 (28.38%)</td><td char="." align="char"/><td align="left">2,842 (27.75%)</td><td align="left">683 (25.49%)</td><td align="left">2,159 (28.55%)</td><td char="." align="char"/></tr><tr><td align="left">&#x0003e;&#x02009;300</td><td align="left">2,146 (17.24%)</td><td align="left">1,128 (18.79%)</td><td align="left">1,018 (15.80%)</td><td char="." align="char"/><td align="left">1,795 (17.53%)</td><td align="left">414 (15.45%)</td><td align="left">1,381 (18.26%)</td><td char="." align="char"/></tr><tr><td align="left">Diet score</td><td align="left">2.48&#x02009;&#x000b1;&#x02009;0.98</td><td align="left">2.48&#x02009;&#x000b1;&#x02009;1.00</td><td align="left">2.48&#x02009;&#x000b1;&#x02009;0.96</td><td char="." align="char">0.831</td><td align="left">2.56&#x02009;&#x000b1;&#x02009;0.99</td><td align="left">2.53&#x02009;&#x000b1;&#x02009;0.98</td><td align="left">2.57&#x02009;&#x000b1;&#x02009;0.99</td><td char="." align="char">0.060</td></tr><tr><td align="left">Diet score category</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.003</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.066</td></tr><tr><td align="left">0&#x02013;1</td><td align="left">2,160 (17.27%)</td><td align="left">1,097 (18.30%)</td><td align="left">1,063 (16.33%)</td><td char="." align="char"/><td align="left">1,529 (14.95%)</td><td align="left">408 (15.41%)</td><td align="left">1,121 (14.79%)</td><td char="." align="char"/></tr><tr><td align="left">2&#x02013;3</td><td align="left">8,442 (67.51%)</td><td align="left">3,961 (66.06%)</td><td align="left">4,481 (68.85%)</td><td char="." align="char"/><td align="left">6,904 (67.52%)</td><td align="left">1,814 (68.53%)</td><td align="left">5,090 (67.17%)</td><td char="." align="char"/></tr><tr><td align="left">4&#x02013;5</td><td align="left">1,902 (15.21%)</td><td align="left">938 (15.64%)</td><td align="left">964 (14.81%)</td><td char="." align="char"/><td align="left">1,792 (17.53%)</td><td align="left">425 (16.06%)</td><td align="left">1,367 (18.04%)</td><td char="." align="char"/></tr><tr><td align="left">Physical activity at goal, n (%)</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.033</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.035</td></tr><tr><td align="left">No</td><td align="left">11,972 (90.16%)</td><td align="left">5,732 (90.74%)</td><td align="left">6,240 (89.63%)</td><td char="." align="char"/><td align="left">9,630 (87.45%)</td><td align="left">2,499 (88.59%)</td><td align="left">7,131 (87.06%)</td><td char="." align="char"/></tr><tr><td align="left">Yes</td><td align="left">1,307 (9.84%)</td><td align="left">585 (9.26%)</td><td align="left">722 (10.37%)</td><td char="." align="char"/><td align="left">1,382 (12.55%)</td><td align="left">322 (11.41%)</td><td align="left">1,060 (12.94%)</td><td char="." align="char"/></tr><tr><td align="left">Systolic blood pressure, mmHg</td><td align="left">132.05&#x02009;&#x000b1;&#x02009;18.96</td><td align="left">133.94&#x02009;&#x000b1;&#x02009;19.51</td><td align="left">130.35&#x02009;&#x000b1;&#x02009;18.28</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">128.49&#x02009;&#x000b1;&#x02009;16.68</td><td align="left">131.29&#x02009;&#x000b1;&#x02009;17.09</td><td align="left">127.53&#x02009;&#x000b1;&#x02009;16.43</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Diastolic blood pressure, mmHg</td><td align="left">76.67&#x02009;&#x000b1;&#x02009;11.45</td><td align="left">75.99&#x02009;&#x000b1;&#x02009;11.58</td><td align="left">77.28&#x02009;&#x000b1;&#x02009;11.29</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">76.35&#x02009;&#x000b1;&#x02009;10.66</td><td align="left">76.15&#x02009;&#x000b1;&#x02009;10.89</td><td align="left">76.42&#x02009;&#x000b1;&#x02009;10.58</td><td char="." align="char">0.253</td></tr><tr><td align="left">HbA1c, %</td><td align="left">8.37&#x02009;&#x000b1;&#x02009;2.05</td><td align="left">8.46&#x02009;&#x000b1;&#x02009;2.05</td><td align="left">8.28&#x02009;&#x000b1;&#x02009;2.04</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">8.25&#x02009;&#x000b1;&#x02009;2.05</td><td align="left">8.33&#x02009;&#x000b1;&#x02009;2.05</td><td align="left">8.23&#x02009;&#x000b1;&#x02009;2.05</td><td char="." align="char">0.019</td></tr><tr><td align="left">HbA1c, mmol/mol</td><td align="left">67.93&#x02009;&#x000b1;&#x02009;22.37</td><td align="left">68.99&#x02009;&#x000b1;&#x02009;22.40</td><td align="left">66.97&#x02009;&#x000b1;&#x02009;22.30</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">66.69&#x02009;&#x000b1;&#x02009;22.39</td><td align="left">67.54&#x02009;&#x000b1;&#x02009;22.40</td><td align="left">66.39&#x02009;&#x000b1;&#x02009;22.38</td><td char="." align="char">0.019</td></tr><tr><td align="left">Body mass index, kg/m<sup>2</sup></td><td align="left">26.03&#x02009;&#x000b1;&#x02009;3.69</td><td align="left">25.94&#x02009;&#x000b1;&#x02009;3.58</td><td align="left">26.10&#x02009;&#x000b1;&#x02009;3.78</td><td char="." align="char">0.009</td><td align="left">25.54&#x02009;&#x000b1;&#x02009;3.56</td><td align="left">25.78&#x02009;&#x000b1;&#x02009;3.50</td><td align="left">25.46&#x02009;&#x000b1;&#x02009;3.58</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Triglycerides, mmol/L</td><td align="left">2.13&#x02009;&#x000b1;&#x02009;2.20</td><td align="left">2.08&#x02009;&#x000b1;&#x02009;2.08</td><td align="left">2.18&#x02009;&#x000b1;&#x02009;2.30</td><td char="." align="char">0.015</td><td align="left">2.02&#x02009;&#x000b1;&#x02009;1.95</td><td align="left">2.02&#x02009;&#x000b1;&#x02009;1.87</td><td align="left">2.02&#x02009;&#x000b1;&#x02009;1.98</td><td char="." align="char">0.985</td></tr><tr><td align="left">Total cholesterol, mmol/L</td><td align="left">4.94&#x02009;&#x000b1;&#x02009;1.29</td><td align="left">4.90&#x02009;&#x000b1;&#x02009;1.30</td><td align="left">4.98&#x02009;&#x000b1;&#x02009;1.29</td><td char="." align="char">0.001</td><td align="left">4.87&#x02009;&#x000b1;&#x02009;1.21</td><td align="left">4.87&#x02009;&#x000b1;&#x02009;1.23</td><td align="left">4.88&#x02009;&#x000b1;&#x02009;1.21</td><td char="." align="char">0.785</td></tr><tr><td align="left">HDL cholesterol, mmol/L</td><td align="left">1.23&#x02009;&#x000b1;&#x02009;0.34</td><td align="left">1.24&#x02009;&#x000b1;&#x02009;0.35</td><td align="left">1.21&#x02009;&#x000b1;&#x02009;0.33</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">1.21&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">1.22&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">1.21&#x02009;&#x000b1;&#x02009;0.33</td><td char="." align="char">0.008</td></tr><tr><td align="left">LDL cholesterol, mmol/L</td><td align="left">2.92&#x02009;&#x000b1;&#x02009;1.00</td><td align="left">2.90&#x02009;&#x000b1;&#x02009;1.03</td><td align="left">2.93&#x02009;&#x000b1;&#x02009;0.97</td><td char="." align="char">0.045</td><td align="left">2.94&#x02009;&#x000b1;&#x02009;0.96</td><td align="left">2.92&#x02009;&#x000b1;&#x02009;1.02</td><td align="left">2.95&#x02009;&#x000b1;&#x02009;0.94</td><td char="." align="char">0.186</td></tr><tr><td align="left">eGFR, ml/min/1.73m<sup>2</sup></td><td align="left">98.11&#x02009;&#x000b1;&#x02009;19.19</td><td align="left">93.93&#x02009;&#x000b1;&#x02009;18.91</td><td align="left">101.90&#x02009;&#x000b1;&#x02009;18.65</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">101.94&#x02009;&#x000b1;&#x02009;14.53</td><td align="left">99.61&#x02009;&#x000b1;&#x02009;15.93</td><td align="left">102.75&#x02009;&#x000b1;&#x02009;13.93</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">UACR, mg/mmol</td><td align="left">2.43 [1.04;5.85]</td><td align="left">2.50 [1.22;7.03]</td><td align="left">2.00 [0.90;4.90]</td><td char="." align="char">0.010</td><td align="left">1.15 [0.70;1.97]</td><td align="left">1.48 [0.90;2.30]</td><td align="left">1.05 [0.65;1.78]</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">ba-PWV measurement, m/s</td><td align="left">16.11&#x02009;&#x000b1;&#x02009;3.24</td><td align="left">17.7&#x02009;&#x000b1;&#x02009;3.35</td><td align="left">15.24&#x02009;&#x000b1;&#x02009;2.88</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">15.35&#x02009;&#x000b1;&#x02009;3.00</td><td align="left">16.00&#x02009;&#x000b1;&#x02009;3.23</td><td align="left">15.12&#x02009;&#x000b1;&#x02009;2.89</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Antihypertensive agents, n (%)</td><td align="left">4,517 (33.74%)</td><td align="left">2,556 (40.15%)</td><td align="left">1,961 (27.93%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td align="left">2,840 (25.48%)</td><td align="left">925 (32.40%)</td><td align="left">1,915 (23.10%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Continuous variables are presented as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or median (interquartile range), while categorical variables are summarized as counts and percentages. Group differences were assessed using Student's t-test, Wilcoxon rank-sum test, or chi-square test</p><p>Abbreviations: CVD&#x02009;=&#x02009;cardiovascular diseases, HbA1c&#x02009;=&#x02009;glycated hemoglobin, eGFR&#x02009;=&#x02009;estimated glomerular filtration rate, UACR&#x02009;=&#x02009;urine albumin-to-creatinine ratio, ba-PWV&#x02009;=&#x02009;brachial-ankle pulse wave velocity</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec15"><title>Association between cumulative BP load and cardio-renal outcomes</title><p id="Par69">As shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, cumulative BP load was significantly associated with both the absolute and relative annual changes in ba-PWV. For the absolute change, the &#x003b2; coefficients and standard error (SE) were 0.239 (0.009), 0.201 (0.009), and 0.150 (0.008) when cumulative SBP load was calculated using targets of &#x0003c;&#x02009;120&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;140&#x000a0;mmHg, respectively. For the relative change, the corresponding &#x003b2; values were 0.014 (0.001), 0.012 (0.001), and 0.009 (0.001). No evidence of multicollinearity was observed, as all variance inflation factor values were &#x0003c;&#x02009;2 across models.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Associations between cumulative BP load and annual changes in ba-PWV with model performance evaluation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">&#x003b2; (SE)</th><th align="left"><italic>P</italic> value</th><th align="left">VIF</th><th align="left">Adjusted R<sup>2</sup> (95%CI)</th></tr></thead><tbody><tr><td align="left" colspan="5">Annual absolute change in ba-PWV</td></tr><tr><td align="left" colspan="5"><italic>Cumulative SBP load</italic></td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg</td><td align="left">0.239 (0.009)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.97</td><td align="left">0.193 (0.180&#x02013;0.200)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg</td><td align="left">0.201 (0.009)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.74</td><td align="left">0.184 (0.169&#x02013;0.191)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg</td><td align="left">0.150 (0.008)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.51</td><td align="left">0.172 (0.158&#x02013;0.180)</td></tr><tr><td align="left" colspan="5">Cumulative DBP load</td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg</td><td align="left">0.143 (0.009)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.59</td><td align="left">0.170 (0.155&#x02013;0.175)</td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg</td><td align="left">0.077 (0.008)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.23</td><td align="left">0.159 (0.145&#x02013;0.165)</td></tr><tr><td align="left" colspan="5">Annual relative change in ba-PWV</td></tr><tr><td align="left" colspan="5"><italic>Cumulative SBP load</italic></td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg</td><td align="left">0.014 (0.001)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.97</td><td align="left">0.200 (0.188&#x02013;0.207)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg</td><td align="left">0.012 (0.001)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.74</td><td align="left">0.192 (0.180&#x02013;0.198)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg</td><td align="left">0.009 (0.001)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.51</td><td align="left">0.182 (0.170&#x02013;0.189)</td></tr><tr><td align="left" colspan="5"><italic>Cumulative DBP load</italic></td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg</td><td align="left">0.009 (0.0005)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.59</td><td align="left">0.182 (0.168&#x02013;0.185)</td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg</td><td align="left">0.005 (0.0005)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td><td char="." align="char">1.23</td><td align="left">0.171 (0.158&#x02013;0.175)</td></tr></tbody></table><table-wrap-foot><p>The &#x003b2; coefficients and p values were adjusted for baseline covariates including age, sex, diabetes duration, blood pressure, HbA1c, BMI, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications. In addition, the number of BP measurements and baseline ba-PWV were also included</p><p>Abbreviations: SE&#x02009;=&#x02009;standard error; VIF&#x02009;=&#x02009;variance inflation factor</p></table-wrap-foot></table-wrap></p><p id="Par70">Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> presents the results of logistic regression models evaluating the associations between cumulative BP load and two binary outcomes: progression of arterial stiffness and incidence of DKD, using different clinically recommended BP targets. After adjusting for potential confounding factors, each SD increase in cumulative SBP load was associated with higher odds of arterial stiffness progression, with odds ratios (OR) of 1.75 (95% CI 1.66&#x02013;1.84), 1.59 (1.51&#x02013;1.67), and 1.42 (1.35&#x02013;1.49) for SBP targets of &#x0003c;&#x02009;120&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;140&#x000a0;mmHg, respectively. For the incidence of DKD, the corresponding ORs were 1.30 (95% CI 1.23&#x02013;1.37), 1.28 (1.21&#x02013;1.34), and 1.23 (1.18&#x02013;1.29), respectively.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Associations of cumulative BP load with arterial stiffness progression and incident diabetic kidney disease. The odds ratios (OR) and 95% confidence intervals (CI) were adjusted for baseline covariates including age, sex, diabetes duration, blood pressure, HbA1c, BMI, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications. In addition, the number of BP measurements was included. Analyses for arterial stiffness progression were additionally adjusted for baseline ba-PWV, while models for incident DKD were adjusted for baseline eGFR</p></caption><graphic xlink:href="12933_2025_2785_Fig2_HTML" id="MO3"/></fig></p><p id="Par71">Restricted cubic spline analyses revealed dose&#x02013;response relationships between cumulative BP load and cardio-renal outcomes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> and Figure <xref rid="MOESM1" ref-type="media">S6</xref>). When cumulative SBP load (target SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg) exceeds 10, arterial stiffness progression risks and DKD incidence increase. As cumulative SBP load continues to rise, the rate of risk increase accelerates, demonstrating a typical J-shaped association. At other BP target values, cumulative BP load also demonstrated nonlinear associations with cardio-renal outcomes (all nonlinear <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Restricted cubic spline curves for the associations of cumulative SBP load with arterial stiffness progression (<bold>A</bold>&#x02013;<bold>C</bold>) and incident DKD (<bold>D</bold>&#x02013;<bold>F</bold>). Cumulative SBP loads were calculated based on target SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg, SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg, and SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg. All models were adjusted for baseline covariates including age, sex, diabetes duration, SBP, HbA1c, BMI, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications. The number of BP measurements was also adjusted. Analyses for arterial stiffness progression were additionally adjusted for baseline ba-PWV, while models for incident DKD were adjusted for baseline eGFR. Solid lines represent multivariable-adjusted odds ratios (ORs), and shaded areas indicate 95% confidence intervals (CIs). Knots for the cumulative BP load were placed at the 5th, 35th, 65th, and 95th percentiles. The Wald test was used to calculate the P values for nonlinearity</p></caption><graphic xlink:href="12933_2025_2785_Fig3_HTML" id="MO4"/></fig></p></sec><sec id="Sec16"><title>Prognostic value of cumulative BP load calculated based on varying targets</title><p id="Par72">For the absolute annual change in ba-PWV, cumulative BP load calculated using a target SBP of &#x0003c;&#x02009;120&#x000a0;mmHg was associated with the highest adjusted R<sup>2</sup> (0.193; 95% CI 0.180&#x02013;0.200) among the target levels tested. Adjusted R<sup>2</sup> values for targets of &#x0003c;&#x02009;130&#x000a0;mmHg and &#x0003c;&#x02009;140&#x000a0;mmHg were 0.184 (95% CI 0.169&#x02013;0.191) and 0.172 (95% CI 0.158&#x02013;0.180), respectively. A similar pattern was observed for the relative annual change in ba-PWV, where the target of &#x0003c;&#x02009;120&#x000a0;mmHg again yielded the highest adjusted R<sup>2</sup> (0.200; 95% CI 0.188&#x02013;0.207) among all SBP targets tested, followed by &#x0003c;&#x02009;130&#x000a0;mmHg (0.192; 95% CI 0.180&#x02013;0.198) and &#x0003c;&#x02009;140&#x000a0;mmHg (0.182; 95% CI 0.170&#x02013;0.189) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). In models predicting arterial stiffness progression, the incorporation of cumulative BP load based on a target of &#x0003c;&#x02009;120&#x000a0;mmHg increased the C-statistic from 0.699 (base model) to 0.726 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Targets of &#x0003c;&#x02009;130&#x000a0;mmHg and &#x0003c;&#x02009;140&#x000a0;mmHg yielded C-statistics of 0.720 and 0.713, respectively. Relative to the base model with traditional risk factors, the addition of cumulative BP load calculated using a target of &#x0003c;&#x02009;120&#x000a0;mmHg was associated with a continuous NRI of 36.8% (95% CI 33.4&#x02013;40.1%). NRIs for the &#x0003c;&#x02009;130&#x000a0;mmHg and &#x0003c;&#x02009;140&#x000a0;mmHg targets were 28.2% (95% CI 24.8&#x02013;31.5%) and 16.2% (95% CI 12.9&#x02013;19.5%), respectively.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Prognostic value of cumulative BP load compared with traditional risk factors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Akaike information criterion</th><th align="left">C-Statistic (95% CI)</th><th align="left">Continuous net reclassification improvement</th></tr></thead><tbody><tr><td align="left" colspan="4">Progression of arterial stiffness</td></tr><tr><td align="left">Base SBP model<sup>*</sup></td><td char="," align="char">16,889</td><td char="&#x02013;" align="char">0.699 (0.690&#x02013;0.708)</td><td align="left">Reference</td></tr><tr><td align="left" colspan="4"><italic>Base model</italic>&#x02009;+&#x02009;<italic>cumulative SBP load</italic></td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg</td><td char="," align="char">16,398</td><td char="&#x02013;" align="char">0.726 (0.718&#x02013;0.735)</td><td align="left">36.8% (33.4&#x02013;40.1%)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg</td><td char="," align="char">16,526</td><td char="&#x02013;" align="char">0.720 (0.712&#x02013;0.729)</td><td align="left">28.2% (24.8&#x02013;31.5%)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg</td><td char="," align="char">16,668</td><td char="&#x02013;" align="char">0.713 (0.704&#x02013;0.722)</td><td align="left">16.2% (12.9&#x02013;19.5%)</td></tr><tr><td align="left">Base DBP model<sup>*</sup></td><td char="," align="char">16,896</td><td char="&#x02013;" align="char">0.698 (0.690&#x02013;0.707)</td><td align="left">Reference</td></tr><tr><td align="left" colspan="4"><italic>Base model</italic>&#x02009;+&#x02009;<italic>cumulative DBP load</italic></td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg</td><td char="," align="char">16,675</td><td char="&#x02013;" align="char">0.711 (0.702&#x02013;0.719)</td><td align="left">28.1% (24.8&#x02013;31.4%)</td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg</td><td char="," align="char">16,823</td><td char="&#x02013;" align="char">0.702 (0.694&#x02013;0.711)</td><td align="left">22.1% (18.9&#x02013;25.3%)</td></tr><tr><td align="left" colspan="4">Incidence of diabetic kidney disease</td></tr><tr><td align="left">Base SBP model<sup>*</sup></td><td char="," align="char">12,076</td><td char="&#x02013;" align="char">0.653 (0.642&#x02013;0.665)</td><td align="left">Reference</td></tr><tr><td align="left" colspan="4"><italic>Base model</italic>&#x02009;+&#x02009;<italic>cumulative SBP load</italic></td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg</td><td char="," align="char">11,987</td><td char="&#x02013;" align="char">0.662 (0.650&#x02013;0.674)</td><td align="left">15.8% (11.5&#x02013;20.0%)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg</td><td char="," align="char">11,989</td><td char="&#x02013;" align="char">0.661 (0.650&#x02013;0.673)</td><td align="left">12.5% (8.3&#x02013;16.7%)</td></tr><tr><td align="left">Target: SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg</td><td char="," align="char">11,997</td><td char="&#x02013;" align="char">0.660 (0.649&#x02013;0.672)</td><td align="left">6.4% (2.3&#x02013;10.6%)</td></tr><tr><td align="left">Base DBP model<sup>*</sup></td><td char="," align="char">12,290</td><td char="&#x02013;" align="char">0.624 (0.612&#x02013;0.636)</td><td align="left">Reference</td></tr><tr><td align="left" colspan="4"><italic>Base model</italic>&#x02009;+&#x02009;<italic>cumulative DBP load</italic></td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg</td><td char="," align="char">12,228</td><td char="&#x02013;" align="char">0.632 (0.620&#x02013;0.644)</td><td align="left">12.8% (8.6&#x02013;16.9%)</td></tr><tr><td align="left">Target: DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg</td><td char="," align="char">12,255</td><td char="&#x02013;" align="char">0.629 (0.617&#x02013;0.641)</td><td align="left">9.6% (5.5&#x02013;13.6%)</td></tr></tbody></table><table-wrap-foot><p>*Base SBP model contained baseline SBP and other traditional risk factors, including age, sex, diabetes duration, HbA1c, body mass index, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications</p><p>*Base DBP model contained baseline DBP and other traditional risk factors, including age, sex, diabetes duration, HbA1c, body mass index, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, history of cardiovascular disease, history of hypertension, and use of antihypertensive medications</p><p>In addition to the common baseline covariates included in the models, baseline ba-PWV was additionally included in the model for arterial stiffness progression, and baseline eGFR was included in the model for incident DKD</p><p>Abbreviations: SBP&#x02009;=&#x02009;systolic blood pressure, DBP&#x02009;=&#x02009;diastolic blood pressure</p></table-wrap-foot></table-wrap></p><p id="Par73">For predicting the incidence of DKD, the cumulative BP load calculated based on a target SBP of &#x0003c;&#x02009;120&#x000a0;mmHg showed a slightly better predictive performance compared to targets of &#x0003c;&#x02009;130&#x000a0;mmHg and &#x0003c;&#x02009;140&#x000a0;mmHg. When cumulative SBP loads, based on target SBP values of &#x0003c;&#x02009;120&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;140&#x000a0;mmHg, were incorporated into the base model, the C-statistic improved from 0.653 to 0.662, 0.661, and 0.660, respectively (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The NRIs for cumulative SBP load were 15.8% (95% CI 11.5&#x02013;20.0%), 12.5% (8.3&#x02013;16.7%), and 6.4% (2.3&#x02013;10.6%), respectively.</p><p id="Par74">For target DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg, cumulative DBP load demonstrated superior predictive ability for cardio-renal outcomes compared to a target DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg.</p></sec><sec id="Sec17"><title>Structural equation model for the progression of arterial stiffness and the incidence of DKD</title><p id="Par75">Structural equation modeling analyses demonstrated good model fits for both outcomes. Specifically, for arterial stiffness progression, the model showed good fit indices (RMSEA&#x02009;=&#x02009;0.037 [SD&#x02009;=&#x02009;0.007], CFI&#x02009;=&#x02009;0.998 [SD&#x02009;=&#x02009;0.001]) and an adequate TLI (0.929 [SD&#x02009;=&#x02009;0.025]). Similarly, the DKD incidence model exhibited a good fit according to RMSEA (0.031 [SD&#x02009;=&#x02009;0.005]) and CFI (0.996 [SD&#x02009;=&#x02009;0.001]), with an adequate TLI (0.937 [SD&#x02009;=&#x02009;0.021]) (Figs.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>, Tables <xref rid="MOESM1" ref-type="media">S4</xref>-<xref rid="MOESM1" ref-type="media">5</xref>).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Structural-equation modeling for the pathways through cumulative SBP load to aortic stiffness progression. The cumulative SBP load was calculated using a target SBP of &#x0003c;&#x02009;120&#x000a0;mmHg. Arrows indicate the direction of regression paths, with the numbers on the paths representing standardized path coefficients. Observable variables are shown as rectangles, and latent variables are shown as ellipses. Only statistically significant paths (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) with path coefficients &#x02265;&#x02009;0.05 are shown for simplicity. The model is adjusted for age and sex.</p></caption><graphic xlink:href="12933_2025_2785_Fig4_HTML" id="MO5"/></fig><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Structural-equation modeling for the pathways through cumulative SBP load to incident diabetic kidney disease. The cumulative SBP load was calculated using a target SBP of &#x0003c;&#x02009;120&#x000a0;mmHg. Arrows indicate the direction of regression paths, with the numbers on the paths representing standardized path coefficients. Observable variables are shown as rectangles, and latent variables are shown as ellipses. Only statistically significant paths (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) with path coefficients &#x02265;&#x02009;0.05 are shown for simplicity. The model is adjusted for age and sex.</p></caption><graphic xlink:href="12933_2025_2785_Fig5_HTML" id="MO6"/></fig></p><p id="Par76">Higher educational level (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.05, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.05), better occupation status (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.07, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.05), and higher annual household income (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.05, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.03) were significantly correlated with lower cumulative SBP load across both outcomes. Conversely, higher baseline HbA1c (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;0.10, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;0.05), BMI (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;0.07, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;0.08), and SBP (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;0.58, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;0.58) were associated with increased cumulative SBP load. Healthier dietary habits also showed significant relationships with reduced cumulative SBP load in both models (&#x003b2;<sub>AS</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.05, &#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.04). Achieving physical activity goals was significantly associated with lower cumulative SBP load only in the DKD incidence model (&#x003b2;<sub>DKD</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.07), but this relationship was not significant in the arterial stiffness progression model. Detailed statistical results, including confidence intervals for each pathway, are available in Supplementary Tables <xref rid="MOESM1" ref-type="media">S4</xref>-<xref rid="MOESM1" ref-type="media">5</xref>.</p><p id="Par77">Sensitivity analyses showed consistent results after excluding participants with a history of cardiovascular diseases (Tables <xref rid="MOESM1" ref-type="media">S6</xref>-<xref rid="MOESM1" ref-type="media">7</xref>). In subgroup analyses stratified by baseline hypertension status, the cumulative SBP load based on a control target of &#x0003c;&#x02009;120&#x000a0;mmHg consistently showed the highest predictive performance among all BP targets tested in both hypertensive and non-hypertensive patients. Similarly, cumulative DBP load calculated using a control target of &#x0003c;&#x02009;80&#x000a0;mmHg performed best across both subgroups (Tables <xref rid="MOESM1" ref-type="media">S8</xref>-<xref rid="MOESM1" ref-type="media">11</xref>). Furthermore, BP TITRE and BP variability were independently associated with the progression of arterial stiffness and the incidence of DKD. However, the predictive performance of BP TITRE and BP variability was inferior to that of cumulative BP load calculated using the predefined control targets (SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg and DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg), as indicated by lower C-statistics and NRI values (Tables <xref rid="MOESM1" ref-type="media">S12</xref>-<xref rid="MOESM1" ref-type="media">13</xref>). In the subsample of participants with BP measurements recorded at baseline, 6 (&#x000b1;&#x02009;1 month), 12 (&#x000b1;&#x02009;1 month), and 18 (&#x000b1;&#x02009;1 month) months, cumulative SBP load was recalculated using only these four time points. The SBP&#x02009;&#x0003c;&#x02009;120 mmHg-based cumulative BP load again demonstrated the highest predictive performance among all BP targets tested for both arterial stiffness progression and incident DKD in this subset, consistent with the findings from the main analysis (Tables <xref rid="MOESM1" ref-type="media">S14</xref>-<xref rid="MOESM1" ref-type="media">15</xref>). In the subsample of participants whose BP was measured using the OMRON HBP-9031C device, the cumulative BP load based on the target of SBP&#x02009;&#x0003c;&#x02009;120 mmHg demonstrated the highest predictive performance among all BP targets tested, for both arterial stiffness progression and incident DKD (Tables <xref rid="MOESM1" ref-type="media">S16</xref>&#x02013;<xref rid="MOESM1" ref-type="media">S17</xref>).</p></sec></sec><sec id="Sec18"><title>Discussion</title><p id="Par78">In this large-scale longitudinal study, we compared the predictive value of cumulative BP load calculated using different blood pressure target values for the progression of arterial stiffness and the incidence of DKD in patients with type 2 diabetes. Our results demonstrated that cumulative BP load with a target of SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg exhibited the most potent predictive capability. Structural equation modeling indicated that socioeconomic factors, including higher education, better occupation, and higher income, were associated with lower cumulative SBP load, potentially through correlations with healthier dietary habits and improved metabolic parameters, which in turn correlated with better cardio-renal outcomes.</p><p id="Par79">Hypertension has been well-established as a shared risk factor for cardiovascular and chronic kidney disease [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. A comprehensive meta-analysis involving 344,716 adults demonstrated that each five mmHg increase in SBP was associated with a 10% higher risk of cardiovascular diseases, a 13% higher risk of stroke, an 8% higher risk of ischemic heart disease, and a 5% higher risk of cardiovascular mortality [<xref ref-type="bibr" rid="CR48">48</xref>]. Similarly, findings from a large community-based hypertension cohort study revealed that the risk of chronic renal failure progressively increased when SBP exceeded 120&#x000a0;mmHg, with every 10&#x000a0;mmHg rise in SBP correlating to a 6% greater risk of CKD [<xref ref-type="bibr" rid="CR49">49</xref>]. While these studies provide strong evidence linking elevated SBP to cardiovascular and renal outcomes, their reliance on single-point blood pressure measurements limits understanding the cumulative impact of blood pressure on target organ damage.</p><p id="Par80">In previous studies, both cumulative BP and cumulative BP load have been used to quantify long-term blood pressure exposure. Cumulative BP refers to the product of blood pressure and time (measured in mmHg&#x02009;&#x000d7;&#x02009;year), which continuously accumulates over the observation period, failing to account for variations in BP [<xref ref-type="bibr" rid="CR11">11</xref>]. Cumulative BP load reflects BP elevations by calculating the proportion of the blood pressure&#x02013;time area under the curve exceeding the target value relative to the total area under the curve. Once a patient's blood pressure is effectively controlled, cumulative BP load decreases accordingly. Therefore, cumulative BP load can sensitively identify high-risk individuals with elevated blood pressure and evaluate the effectiveness of blood pressure interventions.</p><p id="Par81">Recent studies have highlighted the strong association between cumulative BP load and adverse cardiovascular and renal outcomes. Wang et al. demonstrated that elevated cumulative SBP load (target SBP&#x02009;&#x0003c;&#x02009;130&#x000a0;mmHg) significantly increases cardiovascular disease risk in patients with type 2 diabetes [<xref ref-type="bibr" rid="CR16">16</xref>]. Arterial stiffness is a recognized precursor to cardiovascular diseases. Our findings confirmed a significant association between increased cumulative BP load and arterial stiffness progression. Additionally, Park et al. have shown that cumulative SBP load (target SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg) is strongly linked to an elevated risk of chronic kidney disease [<xref ref-type="bibr" rid="CR15">15</xref>]. Given the inconsistencies in target definitions of cumulative SBP load across studies above, we systematically compared the predictive value of cumulative SBP load under three different control targets (SBP&#x02009;&#x0003c;&#x02009;140&#x000a0;mmHg, &#x0003c;&#x02009;130&#x000a0;mmHg, and &#x0003c;&#x02009;120&#x000a0;mmHg). Our results indicated that cumulative SBP load with a target of &#x0003c;&#x02009;120&#x000a0;mmHg demonstrated superior predictive performance, evidenced by improved C-statistics, the highest adjusted R<sup>2</sup> and NRI values among all BP targets tested. We also compared the predictive value of cumulative DBP load under two different control targets (DBP&#x02009;&#x0003c;&#x02009;90&#x000a0;mmHg and DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg), finding that DBP&#x02009;&#x0003c;&#x02009;80&#x000a0;mmHg performed better. Although our findings indicate that cumulative SBP load based on a target of &#x0003c;&#x02009;120&#x000a0;mmHg demonstrated the highest predictive performance, this should not be interpreted as a recommendation for intensive BP lowering for all patients in routine clinical practice. Evidence from prior trials has shown that while more intensive SBP control can improve certain outcomes, it is also associated with an increased risk of hypotension [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Therefore, the adoption of lower SBP targets should be individualized, with close monitoring to ensure safety and tolerability&#x02014;particularly among elderly patients, individuals in poor health, or those with established target organ damage or severe coronary artery disease.</p><p id="Par82">Moreover, our restricted cubic spline analysis revealed that once cumulative SBP load (target SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg) exceeded 10, the risks of arterial stiffness progression and diabetic kidney disease increased. Notably, calculating cumulative BP load requires only routine follow-up data, incurring no additional costs. Thus, we propose that electronic health record (EHR) systems integrate a function to compute cumulative SBP load, similar to body mass index. This feature could trigger timely alerts when a patient's cumulative SBP load exceeds 10, allowing clinicians to intervene early and implement appropriate measures.</p><p id="Par83">To identify potential targets for reducing cumulative BP load, we used structural equation modeling to investigate the pathways linking modifiable risk factors&#x02014;including socioeconomic status, lifestyle behaviors, and metabolic indicators&#x02014;with cumulative SBP load, arterial stiffness progression, and DKD incidence.</p><p id="Par84">Our results indicated that higher educational attainment was linked to better occupational status and higher household income, factors associated with improved blood pressure management. Bin et al. reported that individuals with higher educational attainment and income are more likely to access emerging technologies, such as innovative blood pressure management applications and wearable devices, which can lead to more effective blood pressure management [<xref ref-type="bibr" rid="CR51">51</xref>]. Metabolic control, as reflected by lower baseline HbA1c and BMI, was significantly associated with reduced cumulative SBP load, reinforcing the importance of metabolic management in diabetes care. In both outcome models, healthier dietary habits showed consistent associations with lower cumulative SBP load. However, the relationship between physical activity and cumulative SBP load varied between the two outcomes. Specifically, physical activity was inversely associated with cumulative SBP load in the DKD incidence model, whereas this association was not statistically significant in the arterial stiffness progression model. This discrepancy may partly reflect the methodological characteristics inherent in structural equation modeling. Structural equation modeling simultaneously accounts for multiple correlated pathways and covariates, potentially attenuating or masking certain direct associations observable in simpler regression models [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. In the arterial stiffness progression model, metabolic factors such as HbA1c showed stronger associations and thus may have explained a substantial portion of the variance previously linked with physical activity. Additionally, the self-reported nature of physical activity measurement could introduce potential biases, possibly influencing the observed associations. Future studies employing objective assessment methods, such as accelerometers or multiple-sensor devices, are warranted to clarify the precise relationships among physical activity, cumulative SBP load, and metabolic indicators concerning arterial stiffness progression.</p></sec><sec id="Sec19"><title>Strengths and limitations</title><p id="Par85">This study has several notable strengths. First, it is based on a large-scale, multicenter longitudinal cohort of diabetes patients, with over 100,000 blood pressure measurements, ensuring robust statistical power. Second, we systematically compared the predictive value of cumulative BP load based on varying targets. Third, we applied structural equation modeling to comprehensively evaluate the associations among socioeconomic factors (education, occupation, and income), health behaviors, metabolic indicators, and cumulative blood pressure load across different clinical outcomes.</p><p id="Par86">However, this study has several limitations. First, all blood pressure measurements were obtained using cuff-based devices. Cuff-based devices can be affected by body movement, positional changes, and device-specific algorithms used to interpret oscillometric signals [<xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref>]. To reduce these potential inaccuracies, our study employed BP monitors from a uniform manufacturer (Omron Healthcare), adhered to standardized measurement protocols, and ensured that all personnel underwent stringent training to minimize measurement errors. Second, BP data were based exclusively on clinic measurements. While office BP is commonly used for the diagnosis, classification, and management of hypertension, it does not fully capture short-term fluctuations or nighttime BP patterns [<xref ref-type="bibr" rid="CR57">57</xref>]. Future studies should incorporate out-of-office BP assessments, such as ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), to better capture short-term BP dynamics and improve the accuracy of long-term BP exposure estimation. Third, this study utilized peripheral blood pressure measurements instead of central blood pressure (cBP). Considering that cBP may more accurately reflect the hemodynamic burden on target organs, future research should further investigate its potential clinical utility [<xref ref-type="bibr" rid="CR58">58</xref>]. Fourth, the follow-up duration was relatively short, which limited our ability to assess the long-term impact of cumulative BP load on cardiovascular outcomes. Finally, residual confounding may exist due to unmeasured factors, including genetic predisposition and social determinants such as neighborhood conditions, housing, and access to care.</p></sec><sec id="Sec20"><title>Conclusions</title><p id="Par87">This study demonstrates that cumulative BP load with the target of SBP&#x02009;&#x0003c;&#x02009;120&#x000a0;mmHg has a superior predictive ability for the progression of arterial stiffness and incidence of DKD compared to traditional single office BP measurements. Structural equation modeling further revealed that favorable socioeconomic factors&#x02014;including higher education level, occupational status, and household income&#x02014;were associated with reduced cumulative SBP load through positive correlations with healthy lifestyle behaviors (dietary habits) and improved metabolic indicators (BMI, HbA1c). A lower cumulative SBP load, in turn, was associated with delayed onset of cardio-renal complications. These findings highlight the importance of monitoring long-term cumulative BP load in diabetes management.</p></sec><sec id="Sec21" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12933_2025_2785_MOESM1_ESM.docx"><caption><p>Supplementary Material</p></caption></media></supplementary-material>
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ABPM</term><def><p id="Par6">Ambulatory blood pressure monitoring</p></def></def-item><def-item><term>AIC</term><def><p id="Par7">Akaike information criterion</p></def></def-item><def-item><term>ARV</term><def><p id="Par8">Average real variability</p></def></def-item><def-item><term>AUC</term><def><p id="Par9">Area under the curve</p></def></def-item><def-item><term>ba-PWV</term><def><p id="Par10">Brachial-ankle pulse wave velocity</p></def></def-item><def-item><term>BMI</term><def><p id="Par11">Body mass index</p></def></def-item><def-item><term>BP</term><def><p id="Par12">Blood pressure</p></def></def-item><def-item><term>cBP</term><def><p id="Par13">Central blood pressure</p></def></def-item><def-item><term>CFI</term><def><p id="Par14">Comparative fit index</p></def></def-item><def-item><term>CI</term><def><p id="Par15">Confidence interval</p></def></def-item><def-item><term>CVD</term><def><p id="Par16">Cardiovascular disease</p></def></def-item><def-item><term>DBP</term><def><p id="Par17">Diastolic blood pressure</p></def></def-item><def-item><term>DKD</term><def><p id="Par18">Diabetic kidney disease</p></def></def-item><def-item><term>eGFR</term><def><p id="Par19">Estimated glomerular filtration rate</p></def></def-item><def-item><term>HbA1c</term><def><p id="Par20">Glycated hemoglobin</p></def></def-item><def-item><term>HBPM</term><def><p id="Par21">Home blood pressure monitoring</p></def></def-item><def-item><term>MICE</term><def><p id="Par22">Multiple imputations by chained equations</p></def></def-item><def-item><term>MMC</term><def><p id="Par23">Metabolic Management Center</p></def></def-item><def-item><term>NRI</term><def><p id="Par24">Net reclassification improvement</p></def></def-item><def-item><term>OR</term><def><p id="Par25">Odds ratios</p></def></def-item><def-item><term>RCS</term><def><p id="Par26">Restricted cubic splines</p></def></def-item><def-item><term>RMSA</term><def><p id="Par27">Root mean square error of approximation</p></def></def-item><def-item><term>SBP</term><def><p id="Par28">Systolic blood pressure</p></def></def-item><def-item><term>SD</term><def><p id="Par29">Standard deviation</p></def></def-item><def-item><term>SE</term><def><p id="Par30">Standard error</p></def></def-item><def-item><term>STROBE</term><def><p id="Par31">Strengthening the reporting of observational studies in epidemiology</p></def></def-item><def-item><term>TITRE</term><def><p id="Par32">Time at target</p></def></def-item><def-item><term>TLI</term><def><p id="Par33">Tucker-Lewis index</p></def></def-item><def-item><term>UACR</term><def><p id="Par34">Urine albumin-to-creatinine ratio</p></def></def-item><def-item><term>VIF</term><def><p id="Par35">Variance inflation factor</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Cong Liu, Bangqun Ji, Yao Liang and Juan Shi these have contributed equally to this paper.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We want to express our sincere gratitude to this study's participants and every staff member involved in the project for their invaluable contributions and support.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>W.W., Q.Z., and Y.Z. contributed to the research questions and conceived the study. Statistical analyses were performed by C.L. with assistance from J.S. The initial manuscript draft was prepared by C.L., B.J., Y.L., and J.S., who also contributed to the interpretation of the results. All authors contributed to data collection, patient care, and manuscript revision. W.W., Q.Z., and Y.Z. approved the final draft of the manuscript. W.W., Q.Z., and Y.Z. can take responsibility for the integrity and accuracy of the data analysis.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by grants from Noncommunicable Chronic Diseases-National Science and Technology Major Project (No.2023ZD0508100), Capacity building for multidisciplinary cooperation in diagnosis and treatment of major metabolic diseases (No. Z155080000004), the National Natural Science Foundation of China (No. 82270896), the Shanghai Medical and Health Development Foundation (No. DMRFP_II_01), The Leader Project of the Oriental Talent Program in 2022 (No.153), Shanghai Hospital Development Center (SHDC22022301).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p> The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par88">The study protocol was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and by the ethics committees of all other participating centers. The study design followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par89">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interest</title><p id="Par90">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Collaborators</surname><given-names>GD</given-names></name></person-group><article-title>Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021</article-title><source>Lancet</source><year>2023</year><volume>402</volume><issue>10397</issue><fpage>203</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(23)01301-6</pub-id><pub-id pub-id-type="pmid">37356446</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Collaborators GD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203&#x02013;34.<pub-id pub-id-type="pmid">37356446</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Aznaouridis</surname><given-names>K</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name></person-group><article-title>Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>13</issue><fpage>1318</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2009.10.061</pub-id><pub-id pub-id-type="pmid">20338492</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318&#x02013;27.<pub-id pub-id-type="pmid">20338492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Tuttle</surname><given-names>KR</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Alpers</surname><given-names>CE</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Brosius</surname><given-names>FC</given-names></name><name><surname>Kolkhof</surname><given-names>P</given-names></name><name><surname>Uribarri</surname><given-names>J</given-names></name></person-group><article-title>Molecular mechanisms and therapeutic targets for diabetic kidney disease</article-title><source>Kidney Int</source><year>2022</year><volume>102</volume><issue>2</issue><fpage>248</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2022.05.012</pub-id><pub-id pub-id-type="pmid">35661785</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248&#x02013;60.<pub-id pub-id-type="pmid">35661785</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Sabanayagam</surname><given-names>C</given-names></name><name><surname>Chee</surname><given-names>ML</given-names></name><name><surname>Banu</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Lim</surname><given-names>SC</given-names></name><name><surname>Tai</surname><given-names>ES</given-names></name><name><surname>Coffman</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name></person-group><article-title>Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population</article-title><source>JAMA Netw Open</source><year>2019</year><volume>2</volume><issue>3</issue><fpage>e191540</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.1540</pub-id><pub-id pub-id-type="pmid">30924904</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Sabanayagam C, Chee ML, Banu R, Cheng CY, Lim SC, Tai ES, Coffman T, Wong TY. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population. JAMA Netw Open. 2019;2(3): e191540.<pub-id pub-id-type="pmid">30924904</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>IH</given-names></name><name><surname>Bangalore</surname><given-names>S</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>AM</given-names></name><name><surname>Michos</surname><given-names>ED</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Rossing</surname><given-names>P</given-names></name><name><surname>Zoungas</surname><given-names>S</given-names></name><name><surname>Bakris</surname><given-names>G</given-names></name></person-group><article-title>Diabetes and hypertension: a position statement by the American diabetes association</article-title><source>Diabetes Care</source><year>2017</year><volume>40</volume><issue>9</issue><fpage>1273</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.2337/dci17-0026</pub-id><pub-id pub-id-type="pmid">28830958</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G. Diabetes and hypertension: a position statement by the American diabetes association. Diabetes Care. 2017;40(9):1273&#x02013;84.<pub-id pub-id-type="pmid">28830958</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><etal/></person-group><article-title>Intensive blood-pressure control in patients with Type 2 diabetes</article-title><source>N Engl J Med</source><year>2024</year><pub-id pub-id-type="doi">10.1056/NEJMoa2412006</pub-id><pub-id pub-id-type="pmid">39555827</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Bi Y, Li M, Liu Y, Li T, Lu J, Duan P, Xu F, Dong Q, Wang A, Wang T, et al. Intensive blood-pressure control in patients with Type 2 diabetes. N Engl J Med. 2024. 10.1056/NEJMoa2412006.<pub-id pub-id-type="pmid">39555827</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Guang</surname><given-names>N</given-names></name></person-group><article-title>"Path of the Heart" (The BPROAD Study) addresses optimal systolic blood pressure for patients with diabetes</article-title><source>J Diabetes</source><year>2025</year><volume>17</volume><issue>1</issue><fpage>e70053</fpage><pub-id pub-id-type="doi">10.1111/1753-0407.70053</pub-id><pub-id pub-id-type="pmid">39853709</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Guang N. &#x0201c;Path of the Heart&#x0201d; (The BPROAD Study) addresses optimal systolic blood pressure for patients with diabetes. J Diabetes. 2025;17(1): e70053.<pub-id pub-id-type="pmid">39853709</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Global report on hypertension: the race against a silent killer [<ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240081062">https://www.who.int/publications/i/item/9789240081062</ext-link>]</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Bancks</surname><given-names>MP</given-names></name><name><surname>Carnethon</surname><given-names>MR</given-names></name><name><surname>Greenland</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>YQ</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>VW</given-names></name></person-group><article-title>Trends in prevalence of diabetes and control of risk factors in diabetes among US Adults, 1999&#x02013;2018</article-title><source>JAMA</source><year>2021</year><volume>326</volume><issue>8</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.9883</pub-id><pub-id pub-id-type="pmid">34170288</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wang L, Li X, Wang Z, Bancks MP, Carnethon MR, Greenland P, Feng YQ, Wang H, Zhong VW. Trends in prevalence of diabetes and control of risk factors in diabetes among US Adults, 1999&#x02013;2018. JAMA. 2021;326(8):1&#x02013;13.<pub-id pub-id-type="pmid">34170288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutz</surname><given-names>R</given-names></name><name><surname>Brunstr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>Burnier</surname><given-names>M</given-names></name><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Januszewicz</surname><given-names>A</given-names></name><name><surname>Muiesan</surname><given-names>ML</given-names></name><name><surname>Tsioufis</surname><given-names>K</given-names></name><name><surname>de Pinho</surname><given-names>RM</given-names></name><name><surname>Albini</surname><given-names>FL</given-names></name><name><surname>Boivin</surname><given-names>JM</given-names></name><etal/></person-group><article-title>2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension</article-title><source>Eur J Intern Med</source><year>2024</year><volume>126</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.ejim.2024.05.033</pub-id><pub-id pub-id-type="pmid">38914505</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kreutz R, Brunstr&#x000f6;m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, de Pinho RM, Albini FL, Boivin JM, et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1&#x02013;15.<pub-id pub-id-type="pmid">38914505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Hua</surname><given-names>R</given-names></name><name><surname>Zhong</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name></person-group><article-title>Association of cumulative blood pressure with cognitive decline, dementia, and mortality</article-title><source>J Am Coll Cardiol</source><year>2022</year><volume>79</volume><issue>14</issue><fpage>1321</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2022.01.045</pub-id><pub-id pub-id-type="pmid">35393012</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Li C, Zhu Y, Ma Y, Hua R, Zhong B, Xie W. Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol. 2022;79(14):1321&#x02013;35.<pub-id pub-id-type="pmid">35393012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Fatani</surname><given-names>N</given-names></name><name><surname>Dixon</surname><given-names>DL</given-names></name><name><surname>Van Tassell</surname><given-names>BW</given-names></name><name><surname>Fanikos</surname><given-names>J</given-names></name><name><surname>Buckley</surname><given-names>LF</given-names></name></person-group><article-title>Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension</article-title><source>J Am Coll Cardiol</source><year>2021</year><volume>77</volume><issue>10</issue><fpage>1290</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2021.01.014</pub-id><pub-id pub-id-type="pmid">33706870</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77(10):1290&#x02013;9.<pub-id pub-id-type="pmid">33706870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Parati</surname><given-names>G</given-names></name><name><surname>Ochoa</surname><given-names>JE</given-names></name><name><surname>Lombardi</surname><given-names>C</given-names></name><name><surname>Bilo</surname><given-names>G</given-names></name></person-group><article-title>Assessment and management of blood-pressure variability</article-title><source>Nat Rev Cardiol</source><year>2013</year><volume>10</volume><issue>3</issue><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2013.1</pub-id><pub-id pub-id-type="pmid">23399972</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143&#x02013;55.<pub-id pub-id-type="pmid">23399972</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Catts</surname><given-names>VS</given-names></name><name><surname>Harris</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Numbers</surname><given-names>K</given-names></name><name><surname>Trollor</surname><given-names>J</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><name><surname>Sachdev</surname><given-names>PS</given-names></name><name><surname>Schutte</surname><given-names>AE</given-names></name></person-group><article-title>The contribution of cumulative blood pressure load to dementia, cognitive function and mortality in older adults</article-title><source>J Hypertens</source><year>2024</year><volume>42</volume><issue>11</issue><fpage>1922</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000003808</pub-id><pub-id pub-id-type="pmid">38989713</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Xu X, Catts VS, Harris K, Wang N, Numbers K, Trollor J, Brodaty H, Sachdev PS, Schutte AE. The contribution of cumulative blood pressure load to dementia, cognitive function and mortality in older adults. J Hypertens. 2024;42(11):1922&#x02013;31.<pub-id pub-id-type="pmid">38989713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H-S</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Seong</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Choi</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>HC</given-names></name><name><surname>Jhee</surname><given-names>JH</given-names></name></person-group><article-title>Cumulative blood pressure load and incident CKD</article-title><source>Am J Kidney Dis</source><year>2024</year><volume>84</volume><issue>6</issue><fpage>675</fpage><lpage>685.e671</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2024.05.015</pub-id><pub-id pub-id-type="pmid">39084487</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Park H-S, Park SH, Seong Y, Kim HJ, Choi HY, Park HC, Jhee JH. Cumulative blood pressure load and incident CKD. Am J Kidney Dis. 2024;84(6):675-685.e671.<pub-id pub-id-type="pmid">39084487</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Harris</surname><given-names>K</given-names></name><name><surname>Hamet</surname><given-names>P</given-names></name><name><surname>Harrap</surname><given-names>S</given-names></name><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Poulter</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>Zoungas</surname><given-names>S</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name><name><surname>Chalmers</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cumulative systolic blood pressure load and cardiovascular risk in patients with diabetes</article-title><source>J Am Coll Cardiol</source><year>2022</year><volume>80</volume><issue>12</issue><fpage>1147</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2022.06.039</pub-id><pub-id pub-id-type="pmid">36109108</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Wang N, Harris K, Hamet P, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, Woodward M, Chalmers J, et al. Cumulative systolic blood pressure load and cardiovascular risk in patients with diabetes. J Am Coll Cardiol. 2022;80(12):1147&#x02013;55.<pub-id pub-id-type="pmid">36109108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>YI</given-names></name></person-group><article-title>Li MORAN: Association of cumulative systolic blood pressure load and stroke in patients without diabetes</article-title><source>Eur Heart J</source><year>2023</year><pub-id pub-id-type="doi">10.1093/eurheartj/ehad655.2327</pub-id><pub-id pub-id-type="pmid">37795986</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Zhao Y, Zhang YI. Li MORAN: Association of cumulative systolic blood pressure load and stroke in patients without diabetes. Eur Heart J. 2023. 10.1093/eurheartj/ehad655.2327.<pub-id pub-id-type="pmid">37795986</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>KI</given-names></name><name><surname>Hung</surname><given-names>MH</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name></person-group><article-title>Cumulative blood pressure load and hypertensive nephropathy in Han Chinese hypertensive patients</article-title><source>J Clin Hypertens (Greenwich)</source><year>2024</year><volume>26</volume><issue>2</issue><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1111/jch.14776</pub-id><pub-id pub-id-type="pmid">38291944</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Liu KI, Hung MH, Huang CC, Chen JW. Cumulative blood pressure load and hypertensive nephropathy in Han Chinese hypertensive patients. J Clin Hypertens (Greenwich). 2024;26(2):207&#x02013;16.<pub-id pub-id-type="pmid">38291944</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname><given-names>T</given-names></name><name><surname>Borghi</surname><given-names>C</given-names></name><name><surname>Charchar</surname><given-names>F</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Poulter</surname><given-names>NR</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Schlaich</surname><given-names>M</given-names></name><name><surname>Stergiou</surname><given-names>GS</given-names></name><name><surname>Tomaszewski</surname><given-names>M</given-names></name><etal/></person-group><article-title>2020 International Society of Hypertension global hypertension practice guidelines</article-title><source>J Hypertens</source><year>2020</year><volume>38</volume><issue>6</issue><fpage>982</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000002453</pub-id><pub-id pub-id-type="pmid">32371787</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982&#x02013;1004.<pub-id pub-id-type="pmid">32371787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Evans</surname><given-names>GW</given-names></name><name><surname>Byington</surname><given-names>RP</given-names></name><name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name><name><surname>Grimm</surname><given-names>RH</given-names><suffix>Jr</suffix></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Simons-Morton</surname><given-names>DG</given-names></name><name><surname>Basile</surname><given-names>JN</given-names></name><name><surname>Corson</surname><given-names>MA</given-names></name><name><surname>Probstfield</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Effects of intensive blood-pressure control in type 2 diabetes mellitus</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><issue>17</issue><fpage>1575</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1001286</pub-id><pub-id pub-id-type="pmid">20228401</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575&#x02013;85.<pub-id pub-id-type="pmid">20228401</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>Carey</surname><given-names>RM</given-names></name><name><surname>Aronow</surname><given-names>WS</given-names></name><name><surname>Casey</surname><given-names>DE</given-names><suffix>Jr</suffix></name><name><surname>Collins</surname><given-names>KJ</given-names></name><name><surname>Dennison Himmelfarb</surname><given-names>C</given-names></name><name><surname>DePalma</surname><given-names>SM</given-names></name><name><surname>Gidding</surname><given-names>S</given-names></name><name><surname>Jamerson</surname><given-names>KA</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><etal/></person-group><article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart association task force on clinical practice guidelines</article-title><source>Hypertension</source><year>2018</year><volume>71</volume><issue>6</issue><fpage>1269</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1161/HYP.0000000000000066</pub-id><pub-id pub-id-type="pmid">29133354</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269&#x02013;324.<pub-id pub-id-type="pmid">29133354</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Visseren</surname><given-names>FLJ</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Smulders</surname><given-names>YM</given-names></name><name><surname>Carballo</surname><given-names>D</given-names></name><name><surname>Koskinas</surname><given-names>KC</given-names></name><name><surname>B&#x000e4;ck</surname><given-names>M</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name><name><surname>Biffi</surname><given-names>A</given-names></name><name><surname>Boavida</surname><given-names>JM</given-names></name><name><surname>Capodanno</surname><given-names>D</given-names></name><etal/></person-group><article-title>2021 ESC Guidelines on cardiovascular disease prevention in clinical practice</article-title><source>Eur Heart J</source><year>2021</year><volume>42</volume><issue>34</issue><fpage>3227</fpage><lpage>3337</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehab484</pub-id><pub-id pub-id-type="pmid">34458905</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B&#x000e4;ck M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227&#x02013;337.<pub-id pub-id-type="pmid">34458905</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Ke</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>Ji</surname><given-names>B</given-names></name><etal/></person-group><article-title>The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China</article-title><source>J Diabetes</source><year>2024</year><volume>16</volume><issue>1</issue><fpage>e13466</fpage><pub-id pub-id-type="doi">10.1111/1753-0407.13466</pub-id><pub-id pub-id-type="pmid">37670495</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Gu L, Ma Y, Zheng Q, Gu W, Ke T, Li L, Zhao D, Dai Y, Dong Q, Ji B, et al. The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China. J Diabetes. 2024;16(1): e13466.<pub-id pub-id-type="pmid">37670495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>YM</given-names></name><name><surname>Lei</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><etal/></person-group><article-title>Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK Biobank: a prospective cohort study</article-title><source>EClinicalMedicine</source><year>2023</year><volume>66</volume><fpage>102323</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.102323</pub-id><pub-id pub-id-type="pmid">38024479</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Zhang X, Liu YM, Lei F, Huang X, Liu W, Sun T, Lin L, Zhang P, Cai J, Zhang XJ, et al. Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK Biobank: a prospective cohort study. EClinicalMedicine. 2023;66: 102323.<pub-id pub-id-type="pmid">38024479</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Gan</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>P</given-names></name><etal/></person-group><article-title>Association of body weight time in target range with the risk of kidney outcomes in patients with overweight/obesity and Type 2 diabetes mellitus</article-title><source>Diabetes Care</source><year>2024</year><volume>47</volume><issue>3</issue><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.2337/dc23-1727</pub-id><pub-id pub-id-type="pmid">38079259</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zu C, Liu M, Su X, Wei Y, Meng Q, Liu C, Ye Z, Gan X, Zhang Y, He P, et al. Association of body weight time in target range with the risk of kidney outcomes in patients with overweight/obesity and Type 2 diabetes mellitus. Diabetes Care. 2024;47(3):371&#x02013;8.<pub-id pub-id-type="pmid">38079259</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YB</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Pan</surname><given-names>XF</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Pan</surname><given-names>A</given-names></name></person-group><article-title>Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies</article-title><source>BMJ</source><year>2021</year><volume>373</volume><fpage>n604</fpage><pub-id pub-id-type="doi">10.1136/bmj.n604</pub-id><pub-id pub-id-type="pmid">33853828</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, Liu G, Pan A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373: n604.<pub-id pub-id-type="pmid">33853828</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Paudel</surname><given-names>S</given-names></name><name><surname>Ahmadi</surname><given-names>M</given-names></name><name><surname>Phongsavan</surname><given-names>P</given-names></name><name><surname>Hamer</surname><given-names>M</given-names></name><name><surname>Stamatakis</surname><given-names>E</given-names></name></person-group><article-title>Do associations of physical activity and sedentary behaviour with cardiovascular disease and mortality differ across socioeconomic groups? A prospective analysis of device-measured and self-reported UK Biobank data</article-title><source>Br J Sports Med</source><year>2023</year><volume>57</volume><issue>14</issue><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2022-105435</pub-id><pub-id pub-id-type="pmid">36754587</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Paudel S, Ahmadi M, Phongsavan P, Hamer M, Stamatakis E. Do associations of physical activity and sedentary behaviour with cardiovascular disease and mortality differ across socioeconomic groups? A prospective analysis of device-measured and self-reported UK Biobank data. Br J Sports Med. 2023;57(14):921&#x02013;9.<pub-id pub-id-type="pmid">36754587</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>JC</given-names></name></person-group><article-title>How to apply structural equation modelling to infectious diseases concepts</article-title><source>Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis</source><year>2022</year><volume>28</volume><issue>12</issue><fpage>1567</fpage><lpage>1571</lpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Hurley JC. How to apply structural equation modelling to infectious diseases concepts. Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis. 2022;28(12):1567&#x02013;71.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname><given-names>JB</given-names></name></person-group><article-title>Structural equation modeling for observational studies</article-title><source>J Wildl Manag</source><year>2010</year><volume>72</volume><issue>1</issue><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.2193/2007-307</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Grace JB. Structural equation modeling for observational studies. J Wildl Manag. 2010;72(1):14&#x02013;22.</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name></person-group><article-title>Metabolic management center: an innovation project for the management of metabolic diseases and complications in China</article-title><source>J Diabetes</source><year>2019</year><volume>11</volume><issue>1</issue><fpage>11</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12847</pub-id><pub-id pub-id-type="pmid">30284373</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Zhang Y, Wang W, Ning G. Metabolic management center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2019;11(1):11&#x02013;3.<pub-id pub-id-type="pmid">30284373</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Protecting older people: a high priority during the COVID-19 pandemic</article-title><source>Lancet</source><year>2022</year><volume>400</volume><issue>10354</issue><fpage>729</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(22)01530-6</pub-id><pub-id pub-id-type="pmid">36058217</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Zhang Y, Wang Y, Ning G, He P, Wang W. Protecting older people: a high priority during the COVID-19 pandemic. Lancet. 2022;400(10354):729&#x02013;30.<pub-id pub-id-type="pmid">36058217</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Triglyceride-glucose index trajectory and arterial stiffness: results from hanzhong adolescent hypertension cohort study</article-title><source>Cardiovasc Diabetol</source><year>2022</year><volume>21</volume><issue>1</issue><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/s12933-022-01453-4</pub-id><pub-id pub-id-type="pmid">35216614</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao Y, Chen C, Jia H, Chu C, Zheng W, et al. Triglyceride-glucose index trajectory and arterial stiffness: results from hanzhong adolescent hypertension cohort study. Cardiovasc Diabetol. 2022;21(1):33.<pub-id pub-id-type="pmid">35216614</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Pechlaner</surname><given-names>R</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Kiechl</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name></person-group><article-title>Trajectories of age-related arterial stiffness in chinese men and women</article-title><source>J Am Coll Cardiol</source><year>2020</year><volume>75</volume><issue>8</issue><fpage>870</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2019.12.039</pub-id><pub-id pub-id-type="pmid">32130922</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lu Y, Pechlaner R, Cai J, Yuan H, Huang Z, Yang G, Wang J, Chen Z, Kiechl S, Xu Q. Trajectories of age-related arterial stiffness in chinese men and women. J Am Coll Cardiol. 2020;75(8):870&#x02013;80.<pub-id pub-id-type="pmid">32130922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007; <bold>49</bold>(2 Suppl 2):S12&#x02013;154.</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Roderjan</surname><given-names>CN</given-names></name><name><surname>Cardoso</surname><given-names>CR</given-names></name><name><surname>Ferreira</surname><given-names>MT</given-names></name><name><surname>Muxfeldt</surname><given-names>ES</given-names></name><name><surname>Salles</surname><given-names>GF</given-names></name></person-group><article-title>Correlates of aortic stiffness progression in patients with resistant hypertension: importance of clinic and ambulatory blood pressure changes</article-title><source>J Hypertens</source><year>2015</year><volume>33</volume><issue>4</issue><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000000491</pub-id><pub-id pub-id-type="pmid">25915888</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Roderjan CN, Cardoso CR, Ferreira MT, Muxfeldt ES, Salles GF. Correlates of aortic stiffness progression in patients with resistant hypertension: importance of clinic and ambulatory blood pressure changes. J Hypertens. 2015;33(4):827&#x02013;34.<pub-id pub-id-type="pmid">25915888</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>MT</given-names></name><name><surname>Leite</surname><given-names>NC</given-names></name><name><surname>Cardoso</surname><given-names>CR</given-names></name><name><surname>Salles</surname><given-names>GF</given-names></name></person-group><article-title>Correlates of aortic stiffness progression in patients with type 2 diabetes: importance of glycemic control: the Rio de Janeiro type 2 diabetes cohort study</article-title><source>Diabetes Care</source><year>2015</year><volume>38</volume><issue>5</issue><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.2337/dc14-2791</pub-id><pub-id pub-id-type="pmid">25678104</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Ferreira MT, Leite NC, Cardoso CR, Salles GF. Correlates of aortic stiffness progression in patients with type 2 diabetes: importance of glycemic control: the Rio de Janeiro type 2 diabetes cohort study. Diabetes Care. 2015;38(5):897&#x02013;904.<pub-id pub-id-type="pmid">25678104</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes</article-title><source>Cardiovasc Diabetol</source><year>2023</year><volume>22</volume><issue>1</issue><fpage>167</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-01884-7</pub-id><pub-id pub-id-type="pmid">37415203</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Fang Q, Shi J, Zhang J, Peng Y, Liu C, Wei X, Hu Z, Sun L, Hong J, Gu W, et al. Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes. Cardiovasc Diabetol. 2023;22(1):167.<pub-id pub-id-type="pmid">37415203</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Resche-Rigon</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>IR</given-names></name></person-group><article-title>Multiple imputation by chained equations for systematically and sporadically missing multilevel data</article-title><source>Stat Methods Med Res</source><year>2018</year><volume>27</volume><issue>6</issue><fpage>1634</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1177/0962280216666564</pub-id><pub-id pub-id-type="pmid">27647809</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Resche-Rigon M, White IR. Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res. 2018;27(6):1634&#x02013;49.<pub-id pub-id-type="pmid">27647809</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name><name><surname>Manley</surname><given-names>D</given-names></name></person-group><article-title>Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour</article-title><source>Qual Quant</source><year>2018</year><volume>52</volume><issue>4</issue><fpage>1957</fpage><lpage>1976</lpage><pub-id pub-id-type="doi">10.1007/s11135-017-0584-6</pub-id><pub-id pub-id-type="pmid">29937587</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Johnston R, Jones K, Manley D. Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual Quant. 2018;52(4):1957&#x02013;76.<pub-id pub-id-type="pmid">29937587</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Steyerberg</surname><given-names>EW</given-names></name><name><surname>Vickers</surname><given-names>AJ</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Gerds</surname><given-names>T</given-names></name><name><surname>Gonen</surname><given-names>M</given-names></name><name><surname>Obuchowski</surname><given-names>N</given-names></name><name><surname>Pencina</surname><given-names>MJ</given-names></name><name><surname>Kattan</surname><given-names>MW</given-names></name></person-group><article-title>Assessing the performance of prediction models: a framework for traditional and novel measures</article-title><source>Epidemiology</source><year>2010</year><volume>21</volume><issue>1</issue><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1097/EDE.0b013e3181c30fb2</pub-id><pub-id pub-id-type="pmid">20010215</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128&#x02013;38.<pub-id pub-id-type="pmid">20010215</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Chambless</surname><given-names>LE</given-names></name><name><surname>Cummiskey</surname><given-names>CP</given-names></name><name><surname>Cui</surname><given-names>G</given-names></name></person-group><article-title>Several methods to assess improvement in risk prediction models: extension to survival analysis</article-title><source>Stat Med</source><year>2011</year><volume>30</volume><issue>1</issue><fpage>22</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/sim.4026</pub-id><pub-id pub-id-type="pmid">20827726</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med. 2011;30(1):22&#x02013;38.<pub-id pub-id-type="pmid">20827726</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Marchal-Bressenot</surname><given-names>A</given-names></name><name><surname>Salleron</surname><given-names>J</given-names></name><name><surname>Boulagnon-Rombi</surname><given-names>C</given-names></name><name><surname>Bastien</surname><given-names>C</given-names></name><name><surname>Cahn</surname><given-names>V</given-names></name><name><surname>Cadiot</surname><given-names>G</given-names></name><name><surname>Diebold</surname><given-names>MD</given-names></name><name><surname>Danese</surname><given-names>S</given-names></name><name><surname>Reinisch</surname><given-names>W</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><etal/></person-group><article-title>Development and validation of the Nancy histological index for UC</article-title><source>Gut</source><year>2017</year><volume>66</volume><issue>1</issue><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2015-310187</pub-id><pub-id pub-id-type="pmid">26464414</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, Diebold MD, Danese S, Reinisch W, Schreiber S, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66(1):43&#x02013;9.<pub-id pub-id-type="pmid">26464414</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Bardenheier</surname><given-names>BH</given-names></name><name><surname>Bullard</surname><given-names>KM</given-names></name><name><surname>Caspersen</surname><given-names>CJ</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name></person-group><article-title>A novel use of structural equation models to examine factors associated with prediabetes among adults aged 50 years and older: national health and nutrition examination survey 2001&#x02013;2006</article-title><source>Diabetes Care</source><year>2013</year><volume>36</volume><issue>9</issue><fpage>2655</fpage><lpage>2662</lpage><pub-id pub-id-type="doi">10.2337/dc12-2608</pub-id><pub-id pub-id-type="pmid">23649617</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Bardenheier BH, Bullard KM, Caspersen CJ, Cheng YJ, Gregg EW, Geiss LS. A novel use of structural equation models to examine factors associated with prediabetes among adults aged 50 years and older: national health and nutrition examination survey 2001&#x02013;2006. Diabetes Care. 2013;36(9):2655&#x02013;62.<pub-id pub-id-type="pmid">23649617</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Daire Hooper</surname><given-names>JC</given-names></name><name><surname>Michael</surname><given-names>R</given-names></name></person-group><article-title>Mullen, structural equation modelling: guidelines for determining model fit</article-title><source>Electron J Bus Res Methods</source><year>2008</year><volume>6</volume><issue>1</issue><fpage>53</fpage><lpage>60</lpage></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Daire Hooper JC, Michael R. Mullen, structural equation modelling: guidelines for determining model fit. Electron J Bus Res Methods. 2008;6(1):53&#x02013;60.</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Association of systolic blood pressure variability with cognitive decline in type 2 diabetes: a post hoc analysis of a randomized clinical trial</article-title><source>J Diabetes</source><year>2024</year><volume>16</volume><issue>10</issue><fpage>e70020</fpage><pub-id pub-id-type="doi">10.1111/1753-0407.70020</pub-id><pub-id pub-id-type="pmid">39470149</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Chen J, Zhao X, Liu H, Wang K, Xu X, Wang S, Li M, Zheng R, Zhou L, Bi Y, et al. Association of systolic blood pressure variability with cognitive decline in type 2 diabetes: a post hoc analysis of a randomized clinical trial. J Diabetes. 2024;16(10): e70020.<pub-id pub-id-type="pmid">39470149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>SH</given-names></name><name><surname>Jeon</surname><given-names>JS</given-names></name><name><surname>Noh</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>DC</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name></person-group><article-title>Association between blood pressure and the risk of chronic kidney disease in treatment-na&#x000ef;ve hypertensive patients</article-title><source>Kidney Res Clin Practice</source><year>2022</year><volume>41</volume><issue>1</issue><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.23876/j.krcp.21.099</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Lee H, Kwon SH, Jeon JS, Noh H, Han DC, Kim H. Association between blood pressure and the risk of chronic kidney disease in treatment-na&#x000ef;ve hypertensive patients. Kidney Res Clin Practice. 2022;41(1):31&#x02013;42.</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Kannel</surname><given-names>WB</given-names></name><name><surname>Dawber</surname><given-names>TR</given-names></name><name><surname>Kagan</surname><given-names>A</given-names></name><name><surname>Revotskie</surname><given-names>N</given-names></name><name><surname>Stokes</surname><given-names>J</given-names></name></person-group><article-title>Factors of risk in the development of coronary heart disease&#x02013;six year follow-up experience. The framingham study</article-title><source>Ann Intern Med</source><year>1961</year><volume>55</volume><fpage>33</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-55-1-33</pub-id><pub-id pub-id-type="pmid">13751193</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease&#x02013;six year follow-up experience. The framingham study. Ann Intern Med. 1961;55:33&#x02013;50.<pub-id pub-id-type="pmid">13751193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Collaboration BPLTT. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet (London, England). 2021; <bold>397</bold>(10285):1625&#x02013;1636.</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Hanratty</surname><given-names>R</given-names></name><name><surname>Chonchol</surname><given-names>M</given-names></name><name><surname>Havranek</surname><given-names>EP</given-names></name><name><surname>Powers</surname><given-names>JD</given-names></name><name><surname>Dickinson</surname><given-names>LM</given-names></name><name><surname>Ho</surname><given-names>PM</given-names></name><name><surname>Magid</surname><given-names>DJ</given-names></name><name><surname>Steiner</surname><given-names>JF</given-names></name></person-group><article-title>Relationship between blood pressure and incident chronic kidney disease in hypertensive patients</article-title><source>Clin J Am Soc Nephrol: CJASN</source><year>2011</year><volume>6</volume><issue>11</issue><fpage>2605</fpage><lpage>2611</lpage><pub-id pub-id-type="doi">10.2215/CJN.02240311</pub-id><pub-id pub-id-type="pmid">21921154</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol: CJASN. 2011;6(11):2605&#x02013;11.<pub-id pub-id-type="pmid">21921154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Fine</surname><given-names>LJ</given-names></name><name><surname>Beddhu</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>AK</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Evans</surname><given-names>GW</given-names></name><name><surname>Johnson</surname><given-names>KC</given-names></name><name><surname>Kitzman</surname><given-names>DW</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><etal/></person-group><article-title>Final report of a trial of intensive versus standard blood-pressure control</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>20</issue><fpage>1921</fpage><lpage>1930</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1901281</pub-id><pub-id pub-id-type="pmid">34010531</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384(20):1921&#x02013;30.<pub-id pub-id-type="pmid">34010531</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Perel</surname><given-names>P</given-names></name><name><surname>Mensah</surname><given-names>GA</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name></person-group><article-title>Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension</article-title><source>Nat Rev Cardiol</source><year>2021</year><volume>18</volume><issue>11</issue><fpage>785</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1038/s41569-021-00559-8</pub-id><pub-id pub-id-type="pmid">34050340</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785&#x02013;802.<pub-id pub-id-type="pmid">34050340</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="book"><person-group person-group-type="author"><name><surname>Kline</surname><given-names>RB</given-names></name></person-group><source>Principles and practice of structural equation modeling</source><year>2016</year><publisher-loc>New York</publisher-loc><publisher-name>The Guilford Press</publisher-name></element-citation><mixed-citation id="mc-CR52" publication-type="book">Kline RB. Principles and practice of structural equation modeling. New York: The Guilford Press; 2016.</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Hair JF. Multivariate data analysis, Eighth edition. edn. Andover, Hampshire: Cengage; 2019.</mixed-citation></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Bothe</surname><given-names>TL</given-names></name><name><surname>Kreutz</surname><given-names>R</given-names></name><name><surname>Glos</surname><given-names>M</given-names></name><name><surname>Patzak</surname><given-names>A</given-names></name><name><surname>Pilz</surname><given-names>N</given-names></name></person-group><article-title>Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management</article-title><source>J Hypertens</source><year>2024</year><volume>42</volume><issue>5</issue><fpage>828</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000003632</pub-id><pub-id pub-id-type="pmid">38088417</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Bothe TL, Kreutz R, Glos M, Patzak A, Pilz N. Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management. J Hypertens. 2024;42(5):828&#x02013;40.<pub-id pub-id-type="pmid">38088417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Pilz</surname><given-names>N</given-names></name><name><surname>Picone</surname><given-names>DS</given-names></name><name><surname>Patzak</surname><given-names>A</given-names></name><name><surname>Opatz</surname><given-names>OS</given-names></name><name><surname>Lindner</surname><given-names>T</given-names></name><name><surname>Fesseler</surname><given-names>L</given-names></name><name><surname>Heinz</surname><given-names>V</given-names></name><name><surname>Bothe</surname><given-names>TL</given-names></name></person-group><article-title>Cuff-based blood pressure measurement: challenges and solutions</article-title><source>Blood Press</source><year>2024</year><volume>33</volume><issue>1</issue><fpage>2402368</fpage><pub-id pub-id-type="doi">10.1080/08037051.2024.2402368</pub-id><pub-id pub-id-type="pmid">39291896</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Pilz N, Picone DS, Patzak A, Opatz OS, Lindner T, Fesseler L, Heinz V, Bothe TL. Cuff-based blood pressure measurement: challenges and solutions. Blood Press. 2024;33(1):2402368.<pub-id pub-id-type="pmid">39291896</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Picone</surname><given-names>DS</given-names></name><name><surname>Schultz</surname><given-names>MG</given-names></name><name><surname>Otahal</surname><given-names>P</given-names></name><name><surname>Aakhus</surname><given-names>S</given-names></name><name><surname>Al-Jumaily</surname><given-names>AM</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Bos</surname><given-names>WJ</given-names></name><name><surname>Chambers</surname><given-names>JB</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Cheng</surname><given-names>HM</given-names></name><etal/></person-group><article-title>Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses</article-title><source>J Am Coll Cardiol</source><year>2017</year><volume>70</volume><issue>5</issue><fpage>572</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2017.05.064</pub-id><pub-id pub-id-type="pmid">28750701</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, Bos WJ, Chambers JB, Chen CH, Cheng HM, et al. Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses. J Am Coll Cardiol. 2017;70(5):572&#x02013;86.<pub-id pub-id-type="pmid">28750701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiou</surname><given-names>GS</given-names></name><name><surname>Palatini</surname><given-names>P</given-names></name><name><surname>Parati</surname><given-names>G</given-names></name><name><surname>O'Brien</surname><given-names>E</given-names></name><name><surname>Januszewicz</surname><given-names>A</given-names></name><name><surname>Lurbe</surname><given-names>E</given-names></name><name><surname>Persu</surname><given-names>A</given-names></name><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Kreutz</surname><given-names>R</given-names></name></person-group><article-title>2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement</article-title><source>J Hypertens</source><year>2021</year><volume>39</volume><issue>7</issue><fpage>1293</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000002843</pub-id><pub-id pub-id-type="pmid">33710173</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Stergiou GS, Palatini P, Parati G, O&#x02019;Brien E, Januszewicz A, Lurbe E, Persu A, Mancia G, Kreutz R. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293&#x02013;302.<pub-id pub-id-type="pmid">33710173</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Alsomali</surname><given-names>A</given-names></name><name><surname>Lip</surname><given-names>GYH</given-names></name><name><surname>Akhtar</surname><given-names>R</given-names></name><name><surname>Field</surname><given-names>M</given-names></name><name><surname>Grillo</surname><given-names>A</given-names></name><name><surname>Tidbury</surname><given-names>N</given-names></name><name><surname>Leo</surname><given-names>D</given-names></name><name><surname>Proietti</surname><given-names>R</given-names></name></person-group><article-title>Associations between central and brachial blood pressure in patients with hypertension and aortovascular disease: Implications for clinical practice</article-title><source>Curr Probl Cardiol</source><year>2025</year><volume>50</volume><issue>1</issue><fpage>102874</fpage><pub-id pub-id-type="doi">10.1016/j.cpcardiol.2024.102874</pub-id><pub-id pub-id-type="pmid">39369773</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Alsomali A, Lip GYH, Akhtar R, Field M, Grillo A, Tidbury N, Leo D, Proietti R. Associations between central and brachial blood pressure in patients with hypertension and aortovascular disease: Implications for clinical practice. Curr Probl Cardiol. 2025;50(1): 102874.<pub-id pub-id-type="pmid">39369773</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>